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ABSTRACT 
Using the Experimental Evolution of Long-Lived Yeast Species for Testing 
Evolutionary Theories of Aging 
 
Anastasia Glebov, M.Sc. 
 
Aging of multicellular and unicellular eukaryotic organisms is a highly complex 
biological phenomenon that has various causes and affects numerous processes within 
cells. As a model organism for elucidating the basic biology and molecular mechanisms 
of cellular aging in multicellular eukaryotes, we use the baker’s yeast Saccharomyces 
cerevisiae. The employment of this budding yeast as an advantageous model organism in 
aging research during the past decade has convincingly demonstrated that longevity 
signaling pathways and mechanisms of their modulation by dietary and pharmacological 
interventions are conserved across phyla.  
 
Recently, we designed a chemical genetic screen for small molecules that increase the 
chronological lifespan (CLS) of yeast under caloric restriction (CR) conditions by 
targeting lipid metabolism and modulating housekeeping longevity pathways that 
regulate longevity irrespective of the number of available calories. Our high-throughput 
screen identified a bile acid called lithocholic acid (LCA) as one of such molecules. The 
results of our pharmacophore modeling of the anti-aging potential of various species of 
bile acids imply that the maintenance of the minimal polarity of both the hydrophilic 
(concave) and hydrophobic (convex) sides of the steroid nucleus - by avoiding the 
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presence of polar substituents at the positions 6, 7 and 12 - is mandatory for the extreme 
life-extending efficacy of LCA under CR conditions. Such stringent structural 
requirements are consistent with a target specificity of LCA action as an anti-aging small 
molecule. We found that the life-extending efficacy of LCA under CR exceeds that under 
non-CR conditions, being inversely proportional to the concentration of glucose in 
growth medium and thus in correlation with the extent of calorie supply limitation.  
 
Yeast do not synthesize LCA or any other bile acids produced by mammals. Therefore, 
we propose that bile acids released into the environment by mammals may act as 
interspecies chemical signals providing longevity benefits to yeast and, perhaps, other 
species within an ecosystem. We hypothesize that, because bile acids are known to be 
mildly toxic compounds, they may create selective pressure for the evolution of yeast 
species that can respond to the bile acids-induced mild cellular damage by developing the 
most efficient stress protective mechanisms. It is likely that such mechanisms may 
provide effective protection of yeast against molecular and cellular damage accumulated 
with age. Thus, we propose that yeast species that have been selected for the most 
effective mechanisms providing protection against bile acids may evolve the most 
effective anti-aging mechanisms that are sensitive to regulation by bile acids. We 
analyzed how small anti-aging molecules other than LCA (including resveratrol, caffeine 
and rapamycin) synthesized and released into the environment by one species of the 
organisms composing an ecosystem extend longevity of many other species within this 
ecosystem. Based on such analysis, we extended our initial hypothesis on how bile acids 
govern longevity regulation and drive longevity evolution by suggesting a unified 
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hypothesis of the xenohormetic, hormetic and cytostatic selective forces that impel the 
evolution of longevity regulation mechanisms at the ecosystemic level. 
 
To test the validity of our hypothesis, we carried out the LCA-driven experimental 
evolution of long-lived yeast species. Our serial-batch-transfer type of selection yielded 
three laboratory-evolved yeast strains with greatly extended lifespan. All these strains 
were able to maintain their prolonged lifespan following storage at -80oC and multiple 
successive passages in medium without LCA. We demonstrated that in the absence of 
LCA a mutant allele or alleles selected during the LCA-driven multistep selection process 
of long-lived yeast species extend longevity and alter the age-dependent dynamics of 
mitochondrial respiration under both CR and non-CR conditions. We therefore concluded 
that, consistent with its sought-after effect on longevity regulation pathways, our LCA-
driven multistep selection process under laboratory conditions yielded long-lived yeast 
species whose greatly delayed chronological aging was caused by the selection of a 
mutant allele or alleles that activate housekeeping longevity assurance pathways. As we 
recently demonstrated, these housekeeping longevity assurance pathways modulate 
longevity irrespective of the number of available calories and do not overlap with the 
adaptable longevity pathways that are under the stringent control of calorie availability 
[167]. 
 
We also revealed that under CR conditions in the absence of LCA a mutant allele or 
alleles selected during the LCA-driven multistep selection process of long-lived yeast 
species: 1) enhance the resistance of yeast to chronic oxidative, thermal and osmotic 
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stresses; 2) suppress mitochondria-controlled apoptotic cell death triggered by 
exogenously added hydrogen peroxide; and 3) attenuate lipid-induced necrotic cell death 
induced by exogenously added palmitoleic acid. All these processes are known to be 
governed by the housekeeping longevity assurance pathways that modulate longevity 
irrespective of the number of available calories [167]. 
 
Moreover, the experiments described in this Master’s thesis revealed that the addition of 
LCA to the laboratory-selected long-lived yeast species cultured under CR conditions 1) 
further extends their CLS, although to a lesser degree than that of wild-type (WT) strain; 
2) causes further changes in the age-dependent dynamics of mitochondrial respiration, 
although not as dramatic as those seen in WT; 3) further enhances the resistance of yeast 
to chronic oxidative, thermal and osmotic stresses, although to a lesser extent than those 
observed in WT; 4) further suppresses mitochondria-controlled apoptotic cell death 
triggered by exogenously added hydrogen peroxide, although to a lesser degree than 
those seen in WT; and 5) further attenuates lipid-induced necrotic cell death induced by 
exogenously added palmitoleic acid, although to a lesser extent than those observed in 
WT. These findings imply that, although a mutant allele or alleles selected during the 
LCA-driven multistep selection process of long-lived yeast species greatly impact a 
compendium of the LCA-sensing housekeeping longevity assurance processes, this allele 
or alleles do not activate such processes sufficiently enough to attain the maximal CLS 
achievable under life-extending CR conditions in the presence of LCA.  
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Altogether, these findings provide the comprehensive evidence of our hypothesis in 
which the evolution of longevity regulation mechanisms within an ecosystem can be 
driven by the xenohormetic, hormetic and cytostatic selective forces created by a lasting 
exposure of an organism to an anti-aging natural compound released by other organisms 
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1.1 Longevity is controlled by a signaling network that integrates three signaling 
pathways governing numerous longevity-defining cellular processes 
Aging of multicellular and unicellular eukaryotic organisms is a highly complex 
biological phenomenon, which affects numerous processes within cells. These cellular 
processes include cell cycle, cell growth, stress response, protein folding, apoptosis, 
autophagy, proteasomal protein degradation, actin organization, signal transduction, 
nuclear DNA replication, chromatin assembly and maintenance, ribosome biogenesis and 
translation, lipid and carbohydrate metabolism, oxidative metabolism in mitochondria, 
NAD+ homeostasis, amino acid biosynthesis and degradation, and ammonium and amino 
acid uptake [1 - 36]. Only three nutrient- and energy-sensing signaling pathways have 
been shown to modulate the functional states of all these numerous longevity-defining 
processes and their spatiotemporal organization. These signaling pathways are conserved 
across phyla and include the AMP-activated protein kinase/target of rapamycin 
(AMPK/TOR), cAMP/protein kinase A (cAMP/PKA) and insulin/insulin-like growth 
factor 1 (IGF-1) pathways (Figure 1.1) [4, 10, 25 – 27, 30, 35]. 
 
By operating as an intracellular sensor for the nutrient and energy status, the AMPK/TOR 
pathway regulates longevity in yeast, worms, fruit flies and mammals (Figure 1.1) [37 - 
42]. Being activated in response to the high AMP:ATP ratio characteristic of a low level 
of  nutrients  or  energy  within  a  cell,  AMPK  phosphorylates and inhibits TOR protein  
 2 
Figure 1.1. The functional states of numerous longevity-defining processes and their 
spatiotemporal organization are modulated by only a few nutrient- and energy-sensing 
signaling pathways that are conserved across phyla and include the AMP-activated 
protein kinase/target of rapamycin (AMPK/TOR), cAMP/protein kinase A (cAMP/PKA) 
and insulin/insulin-like growth factor 1 (IGF-1) pathways (see text in section 1.2 for 
details). Reproduced from: Fontana, L., Partridge, L. and Longo, V.D. (2010). Extending 
healthy lifespan - from yeast to humans. Science 328:321-326. 
 
kinase associated  with  several  other  proteins into the TOR complex 1 (TORC1) [37 - 
42]. The resulting inhibition of TORC1 triggers global changes in cell physiology by 1) 
slowing down the processes of cellular growth, ribosome biogenesis and protein 
translation, all of which are extremely energy-consuming; 2) causing a switch from cap-
dependent to cap-independent translation, thereby initiating a distinct pro-longevity 
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translational program; 3) stimulating the removal of damaged macromolecules and 
organelles by activating nutrient- and energy-producing autophagy; 4) accelerating 
mitochondrial synthesis of proteins encoded by mitochondrial genes for core subunits of 
the oxidative phosphorylation protein machinery; and 5) causing global changes in 
mitochondrial gene expression pattern [37, 43 - 45]. Noteworthy, TORC1 can be also 
inhibited in an AMPK-independent manner, in response to low intracellular levels of 
amino acids [39, 41, 46 - 49]. Moreover, if AMPK is phosphorylated by the LKB1 
protein kinase under low nutrient or energy conditions within a cell, it can extend the 
lifespan of worms in a TORC1-independent fashion by slowing down hydrolysis of the 
neutral lipids triacylglycerols (TAG) [50]. 
  
The cAMP/PKA pathway has been shown to regulate longevity in mice and yeast (Figure 
1.1). In mice, this signaling pathway accelerates aging if activated by cAMP produced by 
AC5, an isoform of adenylate cyclase that is highly abundant in the heart and brain [51]. 
By attenuating AMP/PKA signaling in mice, lack of AC5 reduces the inhibitory effect of 
PKA on the Raf/MEK/ERK protein kinase cascade [51]. The resulting activation of the 
protein kinase ERK extends longevity and delays age-related degenerative processes in 
the heart and bone, likely by elevating the level of the reactive oxygen species (ROS) 
scavenging enzyme manganese superoxide dismutase, increasing the resistance of mice 
to oxidative stress and attenuating apoptotic cell death [51]. Recent findings that lack of 
either a catalytic subunit of PKA or its regulatory subunit in mice extends lifespan and 
improves health by attenuating age-related pathologies provided a convincing 
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confirmation for the essential role for cAMP/PKA in regulating longevity and modulating 
physiological processes underlying healthy aging [52 - 53].                
 
In yeast, glucose deprivation attenuates the cAMP/PKA pathway by inhibiting such 
activators of adenylate cyclase Cyr1p as the G protein-coupled receptor Gpr1p, Gα 
protein Gpa2p and two small GTP-binding proteins, Ras1p and Ras2p (Figure 1.1) [54, 
55]. The attenuation of cAMP/PKA signaling in glucose-deprived yeast cells impairs the 
ability of cytosolic PKA to phosphorylate the following three proteins in the cytosol: 1) 
the protein kinase Rim15p (thereby restoring the kinase activity of Rim15p inhibited by 
PKA-dependent phosphorylation); and 2) the stress response transcription factors Msn2p 
and Msn4p (thereby enabling the import of their unphosphorylated forms into the 
nucleus) [56 - 58]. Following their import into the nucleus, the unphosphorylated forms 
of Msn2p and Msn4p collaborate with a nuclear pool of unphosphorylated Rim15p in 
activating transcription of numerous pro-longevity genes that govern carbohydrate 
metabolism, the tricarboxylic acid cycle, trehalose biosynthesis, proteolysis, stress 
protection, ROS detoxification and cell growth regulation [59 - 62]. The resulting 
establishment of such global pro-longevity transcriptional pattern ultimately extends both 
the chronological and replicative lifespans of yeast [56, 63, 64]. Noteworthy, similar to 
the Raf/MEK/ERK signaling cascade in mice [51], its homologous Ste11p/Ste7p/Kss1p 
protein kinase cascade in yeast is attenuated by PKA [65]. Therefore, if the 
Ste11p/Ste7p/Kss1p protein kinase cascade is active due to reduced PKA signaling, it 
promotes longevity of chronologically aging yeast [65]. Such a pro-longevity effect of 
the Ste11p/Ste7p/Kss1p cascade in yeast under conditions of attenuated cAMP/PKA 
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signaling is synergistic with the pro-longevity action of the nuclear forms of Msn2p, 
Msn4p and Rim15p not subjected to phosphorylation by cytosolic PKA (see above) [65]. 
 
Unlike the AMPK/TOR and cAMP/PKA signaling pathways that regulate longevity by 
acting as sensors of the nutrient and energy status of an individual eukaryotic cell, the 
insulin/IGF-1 signaling pathway regulates longevity in worms, fruit flies and mice by 
responding to an endocrine signal that monitors the nutritional status of the whole 
organism (Figure 1.1) [66]. The insulin/IGF-1 pathway responds to an insulin-like ligand 
by stimulating a phosphatidylinositol-3-kinase, which then activates a cascade of protein 
kinases that ultimately cause phosphorylation of a Forkhead box type O (FoxO) family 
transcription factor and its sequestration in the cytosol [67, 68]. Reduced signaling 
through the insulin/IGF-1 pathway inhibits phosphorylation of a FoxO transcription 
factor (DAF-16 in worms, dFOXO in fruit flies and FoxO1 in mice), thereby permitting 
its import into the nucleus [69]. After being imported into the nucleus, the FoxO 
transcription factor orchestrates the establishment of a global life-extending 
transcriptional pattern by activating or repressing transcription of numerous longevity-
defining genes involved in metabolism, detoxification, apoptosis, stress response, 
transcription, translation, signaling and development [70, 71]. 
 
By sharing several protein kinases and adaptor proteins, the AMPK/TOR, cAMP/PKA 
and insulin/IGF-1 signaling pathways converge into a network that regulates longevity in 
yeast, worms, fruit flies and mammals [4, 35 - 38]. In addition to the well-known 
individual protein components of the AMPK/TOR, cAMP/PKA and insulin/IGF-1 
 6 
pathways, this network includes several proteins that currently are not viewed as being in 
any of these signaling pathways; among these proteins are 1) Rtg2p in yeast; 2) CLK-1, 
ISP-1, JNK, MST-1, PHA-4, Rictor/TORC2/SGK-1, SIR-2.1, SKN-1 and SMK-1 in 
worms; 3) dSir2 and JNK in fruit flies; and 4) MCLK, P66Shc, SIRT1, SIRT6, and SIRT7 
in mammals [4, 36, 72 - 74]. Importantly, this longevity regulation network responds to 
the age-related partial mitochondrial dysfunction and to fluctuations in the intracellular 
concentration of mitochondrially produced ROS [36, 37, 73, 75]. By sensing the 
nutritional status of the whole organism as well as the intracellular nutrient and energy 
status, functional state of mitochondria, and concentration of ROS produced in 
mitochondria, the longevity network regulates lifespan across species by coordinating 
information flow along its convergent, divergent and multiply branched signaling 
pathways. 
 
1.2 Some dietary regimens can extend longevity and improve health  
By altering the organismal and intracellular nutrient and energy status, nutrient intake 
plays an important role in defining both lifespan and healthspan [7, 76 - 78]. The dietary 
regimens known as caloric restriction (CR) and dietary restriction (DR) are known not 
only to exhibit a robust longevity-extending effect in evolutionarily distant organisms 
ranging from yeast to rhesus monkeys, but also to improve health by attenuating age-
related pathologies and delaying the onset of age-related diseases across phyla (Table 
1.1) [76 - 83]. A CR diet reduces the intake of calories without compromising the supply 
of amino acids, vitamins and other nutrients [77 - 80]. In contrast, a DR dietary regimen 
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reduces the intake of nutrients (but not necessarily of calories) by limiting food supply 
without causing malnutrition [76, 81 - 83].      
 
Table 1.1. Caloric restriction (CR) and dietary restriction (DR) exhibit a robust 
longevity-extending effect in evolutionarily distant organisms ranging from yeast to 
rhesus monkeys and improve health by attenuating age-related pathologies and delaying 
the onset of age-related diseases across phyla. Adapted from Fontana, L., Partridge, L. 
and Longo, V.D. (2010). Extending healthy lifespan - from yeast to humans. Science 
328:321-326 with modifications. 
 
Organism Life-span increase by CR or DR Health improvement by CR or DR  
Yeast 3-fold (chronological lifespan) Extended reproductive period 
Worms 2- to 3-fold Resistance to misexpressed toxic 
proteins 
Fruit flies 2-fold None reported 
Mice 30-50% Protection against cancer, diabetes, 
atherosclerosis, cardiomyopathy, 
autoimmune, kidney and respiratory 
diseases; reduced neurodegeneration 
Rhesus monkeys Tend noted Prevention of obesity; protection 
against cancer, diabetes and 
cardiovascular disease 
Humans Not tested  Prevention of obesity, diabetes, 
hypertension; reduced risk factors for 
cancer and cardiovascular disease 
 
In a “TOR-centric” model of longevity regulation, AMPK/TOR is the only signaling 
pathway that underlies all life-extending and health-improving effects of CR and DR [84 
- 89]. According to this model, TORC1 - a core protein complex governing the 
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AMPK/TOR pathway - performs three functions that are pivotal to the beneficial effects 
of CR and DR on longevity and healthspan. First, TORC1 integrates the flow of 
information on the organismal and intracellular nutrient and energy status from AMPK (a 
protein kinase in the AMPK/TOR pathway), PKA (a protein kinase in the cAMP/PKA 
pathway), PKB/AKT (a protein kinase in the insulin/IGF-1 pathway), ERK1/2 (a protein 
kinase in the Raf/MEK/ERK signaling cascade) and P66Shc (a mitochondria-confined 
sensor of the redox status within this organelle) [84 - 86]. Second, TORC1 operates 
(independently of AMPK) as a sensor of the intracellular levels of amino acids [84 - 86]. 
Third, by gathering and processing the information on the organismal and intracellular 
nutrient, energy and redox status and amino acid availability, TORC1 governs numerous 
longevity-related processes independently of sirtuins [84 - 86]. The validity of the TOR-
centric model for TORC1-orchestrated modulation of the life-extending effects of CR 
and DR has been confirmed in worms and replicatively aging yeast. In fact, DR is unable 
to extend longevity of worms with reduced TOR signaling [88, 89]. Furthermore, lack of 
key components of the TOR signaling pathway eliminates the beneficial effect of CR on 
the replicative lifespan of yeast [87]. 
 
Although in replicatively aging yeast the TOR pathway alone mediates the longevity 
benefit associated with CR, the life-extending effect of this dietary regimen in 
chronologically aging yeast relies on a signaling network in which the protein kinase 
Rim15p operates as a nutritional integrator of the TOR and cAMP/PKA pathways; it 
seems that this network also includes some other, yet to be identified signaling pathways 
that are not converged on Rim15p [35]. Furthermore, because the AMPK/TOR, 
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cAMP/PKA and insulin/IGF-1 pathways in worms, fruit flies and mammals are known to 
converge into a complex network regulating their longevity (see above) [4, 7, 36 - 38], it 
is likely that these three divergent and multiply branched signaling pathways equally 
contribute to the life-extending effects of CR and DR in these organisms [4, 90 - 99]. The 
emerging concept of a signaling network (rather than the AMPK/TOR pathway alone) 
that mediates the longevity benefit associated with CR and DR by coordinating 
information flow along its convergent, divergent and multiply branched signaling 
pathways has been recently supported by studies in worms. Specifically, it has been 
demonstrated that the life-extending efficacies of different DR regimens in these 
organisms depend on both independent and overlapping signaling pathways [100]. 
 
1.3 Some pharmacological interventions can delay aging and attenuate age-
related pathologies 
CR and DR are not the only interventions known to extend longevity in evolutionarily 
distant organisms. Aging can be slowed down, health improved, age-related pathologies 
attenuated and the onset of age-related diseases delayed also by certain small molecules, 
many of which exhibit the beneficial effects on longevity and healthspan in organisms 
across phyla (Table 1.2). Many of these longevity- and healthspan-extending 
pharmacological interventions target the AMPK/TOR signaling pathway known to 
modulate longevity in response to the intracellular nutrient and energy status. Metformin, 
a type 2 diabetes therapeutics that activates AMPK, extends longevity in worms and mice 
by reducing TORC1 signaling (Table 1.2) [107, 108]. Methionine sulfoximine, a 
glutamine synthetase inhibitor that attenuates TORC1 signaling by decreasing the 
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intracellular concentration of the TORC1 activator glutamine, extends chronological 
lifespan in yeast (Table 1.2) [110, 111]. LY294002 and U0126, which lower TORC1 
signaling by inhibiting upstream TORC1 activators PI3K and MEK (respectively), 
increase the replicative lifespan of cultured human fibrosarcoma cells (Table 1.2) [136]. 
By acting through FKBP12 to inhibit TORC1, the macrocyclic lactone rapamycin has 
been shown to 1) extend longevity in fruit flies and mice [113, 116]; 2) increase the 
replicative lifespans of cultured rodent fibroblasts, human epithelium cells and human 
fibrosarcoma cells [117]; and 3) prolong the replicative and chronological lifespans of 
yeast (Table 1.2) [56, 110, 114]. Moreover, the xanthine alkaloid caffeine has been 
demonstrated to increase chronological lifespan in yeast by reducing the catalytic activity 
of Tor1p (Table 1.2) [101].  
 
Table 1.2. Known anti-aging compounds, their abilities to increase lifespan in different 
organisms (under caloric or dietary restriction [CR or DR, respectively], on a standard 
diet or fed a high-calorie diet), and the mechanisms of their anti-aging action. 
Compound  
 
Increases lifespan* Mechanism  




Caffeine Not tested (NT)  
 
+ (yeast, CLS) 
[101]  
 




governed by the TOR 
pathway [37, 102] 






transcription of genes 








processes [103] known 
to be influenced by 
age-related chromatin 
reorganization [104] 
Lipoic acid, propyl 




+ (nematodes [105] 
(all); fruit flies 
[106] (lipoic acid))  
 
Antioxidants that may 















[107]; mice [108])  
 
Type 2 diabetes 
therapeutics that - by 
activating 
LKB1/AMPK 
signaling and thereby 
inhibiting TORC1 [38, 
109] - modulate 
unspecified longevity-
related processes [107, 
108] known to be 
governed by the TOR 















increases lifespan - 











A serotonin receptor 
antagonist used as an 
antidepressant in 
humans; may increase 
lifespan by inhibiting 
neurotransmission 
related to food 
sensing, thereby 






+ (fruit flies) [113] 
 
+ (yeast, CLS [101, 
110, 114] and RLS 
[115]; fruit flies 




cells - all RLS 
[110])  
 
By inhibiting TORC1 
(yeast and fruit flies) 
[101, 102, 113, 114] 
and mTORC1 
(mammals) [38, 102, 
116], increases 
lifespan by activating 
macroautophagy (yeast 
and fruit flies) [113, 
118] and inhibiting 
cap-dependent protein 
translation (fruit flies 
and mice) [113, 116] 





resistance (yeast) [110, 
115], and increasing 
neutral lipid levels 
(fruit flies) [113] 
Resveratrol 
 
- (yeast, RLS [119]; 
fruit flies [120]; 
mice [121])  
 
+ (yeast, RLS [119] 
but not CLS [119]; 
nematodes [120]; 
fruit flies [120]; 
fishes [122]; mice 





 span by modulating a 
number of longevity-










mitochondrial number,  
reducing IGF-1 levels, 
activating AMPK and 
PGC-1α, promoting 
ER stress response, 
repressing 
transcription of PPAR-
γ, inhibiting adipocyte 
differentiation, 





autophagy [119, 121, 
123 - 131]; its life-
extending ability in 
yeast, nematodes and 
fruit flies depends on 
Sir2p - a member of 











+ (fungi, daphnias, 
fruit flies, mice) 
[132]  
 
By being specifically 
targeted to 
mitochondria, acts as 
an antioxidant that 
may increase lifespan 
by preventing 
oxidative damage to 





induced apoptosis and 
necrosis, and/or 
slowing down the age-
related 
phosphorylation of 







PBMC,RLS) [133]  
 
By activating 
expression of the 
human sirtuin SIRT1 
and thereby increasing 
the extent of SIRT1-
dependent histone H4 
lysine 16 
deacetylation, may 
cause the development 
of an anti-aging 
pattern of transcription 
of numerous genes 







+ (yeast, CLS; 
nematodes; fruit 
flies; human 
PBMC, RLS) [134]  
 
By inhibiting histone 
acetyltransferases and 
promoting histone H3 
deacetylation, 




genes; the resulting 
induction of autophagy 
suppresses age-related 
necrotic cell death 
[134] 







Is used as a mood 
stabilizer and an 
anticonvulsant in 
humans; may increase 
lifespan by promoting 
nuclear localization of 
the DAF-16 forkhead 
transcription factor, 
thereby reducing the 












An inhibitor of 
phosphatidylinositol-
3-kinase that – by 
reducing mTORC1 
signaling [37, 102] – 
modulates unspecified 
longevity-related 
processes [136] known 
to be governed by the 










An inhibitor of the 
protein kinase MEK 
that – by reducing 
mTORC1 signaling 
[37, 102] – modulates 
unspecified longevity-
related processes [136] 
known to be governed 
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by the TOR pathway 
[37, 38, 102] 
 
* Mean, median and/or maximum lifespans. 
** Nematodes carrying mutations that mimic DR under non-DR conditions [103, 105]. 
*** The ability of mianserin to increase nematode lifespan can only be seen in liquid 
media [112], whereas in solid media the compound reduces lifespan [137]. 
**** Increases the replicative lifespan of yeast grown under non-CR conditions [119] only 
in one out of four different yeast strain backgrounds [138]; one group has been unable to 
reproduce the lifespan extension by resveratrol in nematodes and fruit flies [139]; 
increases the life of mice only if fed a high-calorie diet, but not a standard diet [121, 124]. 
***** Although the life-extending ability of resveratrol in yeast, nematodes and fruit flies 
depends on Sir2p [119, 120, 125], it is currently debated whether this anti-aging 
compound binds to Sir2p (or SIRT1, a mammalian sirtuin) in vivo and/or activates Sir2p 
or SIRT1 in living cells [126, 138 - 142]; importantly, resveratrol has been shown to 
inhibit or activate many proteins other than sirtuins by interacting with them [143, 144].   
Abbreviations: AMPK, the AMP-activated serine/threonine protein kinase; CLS, 
chronological lifespan; IGF-1, insulin-like growth factor 1; LKB1, a serine/threonine 
protein kinase that phosphorylates and activates AMPK; mTORC1, the mammalian target 
of rapamycin complex 1; NT, not tested; PBMC, peripheral blood mononuclear cells; 
PGC-1α, peroxisome proliferator-activated receptor-γ co-activator 1α; RLS, replicative 
lifespan; TORC1, the yeast target of rapamycin complex 1. 
 
Some anti-aging compounds extend longevity by targeting the insulin/IGF-1 pathway, 
which monitors the nutritional status of the whole organism. By modulating an upstream 
step in this signaling pathway, the serotonin receptor antagonist mianserin (which is used 
as an antidepressant in humans) increases lifespan in worms, likely by inhibiting 
neurotransmission related to food sensing and mimicking a DR-like physiological state 
(Table 1.2) [112]. A downstream step in this signaling pathway is a target of valproic 
acid (a mood stabilizer and an anticonvulsant in humans), which extends longevity in 
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worms by promoting the translocation of the pro-longevity FoxO transcriptional factor 
DAF-16 into the nucleus (Table 1.2) [135]. 
 
Some anti-aging small molecules extend longevity, improve health and attenuate age-
related pathologies by modulating longevity-defining processes controlled by proteins 
that are not viewed as components of the AMPK/TOR, cAMP/PKA and insulin/IGF-1 
signaling pathways but are dynamically integrated into a longevity regulation network 
(see section 1.1 in this chapter of the thesis) governed by these pathways. One of such 
longevity-extending molecules is resveratrol, a small polyphenol produced by plants 
(Table 1.2). Although the demonstrated by in vitro studies ability of resveratrol to 
activate the protein deacetylase activities of the sirtuins Sir2p (yeast), SIR-2.1 (worms), 
dSir2 (fruit flies) and SIRT1 (mammals) [131, 145] is disputed [142, 146], it has been 
shown to modulate activities of many other longevity-related proteins by interacting with 
them [143, 144] – thereby influencing a number of longevity-defining processes [119, 
121, 124 - 127, 129]. It is likely that the resveratrol-driven modulation of activities of 
numerous longevity-defining proteins and processes they govern underlies the observed 
ability of this small polyphenol molecule 1) to extend replicative (but not chronological) 
lifespan in yeast [119]; 2) to increase the replicative lifespan of cultured human 
fibroblasts [123]; and 3) to extend longevity of worms, fruit flies, fishes and mice [120 - 
122, 124] (Table 1.2). 
 
Similar to resveratrol, sodium nitroprusside exhibits a potent anti-aging effect by 
stimulating sirtuin-dependent protein deacetylation. Unlike resveratrol, sodium 
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nitroprusside activates transcription of the gene encoding sirtuin SIRT1 [133]. The 
resulting enhancement of SIRT1-driven deacetylation of lysine 16 in histone H4 may 
underlie the observed establishment of an anti-aging pattern of transcription and the 
concomitant replicative lifespan extension in cultured human peripheral blood 
mononuclear cells (PMBC) (Table 1.2) [133]. 
 
Reduced histone acetylation is a longevity-extending process that can be stimulated not 
only by sodium nitroprusside, but also by spermidine. This natural polyamine has been 
shown to inhibit histone acetyltransferases and activate histone H3 deacetylation, thereby 
activating transcription of numerous autophagy-related genes, suppressing age-related 
necrotic cell death and ultimately extending the chronological lifespan of yeast, the 
replicative lifespan of cultured human PMBC, and longevity of worms and fruit flies 
(Table 1.2) [131, 134]. Noteworthy, histone modification is also a target of another 
longevity-extending compound, Li+. The ability of this alkali metal ion to cause the age-
related chromatin reorganization by altering transcription of genes involved in histone 
methylation, nucleosome composition and chromatin structure may underlie its beneficial 
properties as a mood stabilizer in humans and an anti-aging compound in worms (Table 
1.2) [103]. 
 
Mitochondria are known to play a pivotal role in longevity regulation across phyla [36, 
73, 75, 147]. Therefore, it is not surprisingly that several anti-aging compounds extend 
longevity by influencing longevity-defining processes confined to or governed by these 
organelles. SkQ1, a plastoquinone derivate, is sorted to mitochondria and operates as an 
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antioxidant that attenuates oxidative damage to mitochondrial proteins and lipids, 
changes mitochondrial morphology, and impairs mitochondria-controlled forms of 
apoptotic and necrotic cell death caused by an excessive accumulation of mitochondria-
produced hydrogen peroxide (Table 1.2) [132]. By influencing these longevity-defining 
processes in mitochondria, SkQ1 not only extends longevity in fungi, daphnias, fruit flies 
and mice, but also improves health and delays the onset of age-related diseases in mice 
[132]. Furthermore, longevity in worms and fruit flies can be extended by the thermal 
stress mimetics lipoic acid, propyl gallate, trolox and taxifolin; all these compounds may 
delay aging by detoxifying free radicals and enhancing resistance to age-related oxidative 
stress (Table 1.2) [106, 105]. 
 
It is important to emphasize that all anti-aging compounds known until recently have 
been called “CR mimetics” and “DR mimetics” because they: 1) similar to CR and DR 
dietary regimens, increase lifespan and/or healthspan under non-CR or non-DR 
conditions;  2) unlike CR and DR diets, do not restrict caloric and nutrient intake; and 3) 
mimic life-extending and health-improving effects of CR and DR on metabolic pathways, 
physiological processes, stress response and gene expression (Table 1.2) [148 - 150]. 
Furthermore, as detailed in Table 1.2, almost all longevity-extending compounds known 
prior to the study presented in this thesis target the AMPK/TOR and insulin/IGF-1 
pathways and impact the sirtuin-governed protein deacetylation module of the longevity 
signaling network that integrates these pathways. As it has been mentioned in sections 
1.1 and 1.2, this network defines longevity only in response to the organismal and 
intracellular nutrient and energy status. Moreover, such CR mimetics and DR mimetics as 
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resveratrol, metformin and mianserin beneficially influence lifespan and healthspan only 
under non-CR or non-DR conditions, but do not extend longevity or improve health if the 
supply of calories or nutrients is limited (Table 1.2) [107, 112, 119 - 121]. Therefore, we 
coined the term “adaptable” to define the AMPK/TOR, cAMP/PKA and insulin/IGF-1 
signaling pathways and sirtuin-governed protein deacetylation module - because they all 
are integrated into the longevity regulation network targeted by the currently known anti-
aging CR mimetics and DR mimetics. The term “adaptable” emphasizes the fact that all 
these pathways and the sirtuin-governed module exhibit the beneficial effects on 
longevity and attenuate age-related pathologies only in response to certain changes in the 
extracellular and intracellular nutrient and energy status of an organism. It is important to 
mention, however, that recent studies revealed that Li+ in worms and rapamycin in fruit 
flies can extend lifespan even under DR conditions – although their longevity-extending 
efficacy under such nutrient-limited conditions is significantly lower than that under non-
CR conditions (Table 1.2) [103, 113]. Based on these findings, we thought that some 
longevity assurance pathways could be “constitutive” or “housekeeping” by nature, 
assuming that they 1) modulate longevity irrespective of the extracellular and 
intracellular nutrient and energy status – in contrast to the adaptable AMPK/TOR, 
cAMP/PKA and insulin/IGF-1 signaling pathways and sirtuin-governed protein 
deacetylation module; and 2) do not overlap (or only partially overlap) with the adaptable 
pathways that are under the stringent control of calorie and nutrient availability.  
 
1.4 Baker’s yeast as an advantageous model organism for elucidating 
mechanisms of cellular aging in multicellular eukaryotes 
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The budding yeast Saccharomyces cerevisiae, a unicellular eukaryote, is a valuable 
model for studying the basic biology of aging and revealing longevity regulation 
mechanisms in multicellular eukaryotes [6, 34, 152]. Two different paradigms of aging 
are known for this unicellular eukaryotic organism, which is amenable to comprehensive 
biochemical, genetic, cell biological, chemical biological and system biological analyses. 
In the replicative aging paradigm, yeast aging is defined by the maximum number of 
daughter cells (buds) that a mother cell can form before becoming senescent (Figure 1.2) 
[6, 31]. Replicative aging in yeast mimics aging of dividing (“mitotic”) cells in a 
multicellular eukaryotic organism [6, 31]. In the chronological aging paradigm, yeast 
aging is defined by the length of time during which a cell remains viable following entry 
into a non-proliferative quiescent state (Figure 1.2) [6, 63, 152]. Chronological aging in 
yeast is an advantageous model for elucidating aging of non-dividing (“post-mitotic”) 
cells in a multicellular eukaryotic organism [6, 63, 152]. Yeast chronological aging is 
assessed using a simple clonogenic assay, which measures the percentage of yeast cells 
that remain viable at different time points following the entry of a cell population into the 
non-proliferative stationary phase [63]. A CR diet, which in yeast can be imposed by 
reducing the initial glucose concentration in a growth medium from 2% to 0.5% or lower, 
decelerates both replicative and chronological aging of yeast [6, 35, 63, 151].   
 
As it has been mentioned in sections 1.1, 1.2 and 1.3 of this Master’s thesis, longevity 




















Figure 1.3. Two different paradigms of yeast aging. In the replicative aging paradigm, 
yeast aging is defined by the maximum number of daughter cells that a mother cell can 
produce before becoming senescent. Replicative aging in yeast mimics aging of dividing 
(“mitotic”) cells in a multicellular eukaryotic organism. In the chronological aging 
paradigm, yeast aging is defined by the length of time during which a cell remains viable 
following entry into a non-proliferative state. Chronological aging in yeast is an 
advantageous model for studying aging of non-dividing (“post-mitotic”) cells in a 
multicellular eukaryotic organism. Yeast chronological aging is assessed using a simple 
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clonogenic assay, which measures the percentage of yeast cells that remain viable at 
different time points following the entry of a cell population into the non-proliferative 
stationary phase. (See text in section 1.5 for details). Reproduced from [151].  
 
interventions are conserved across phyla. It should be emphasized that the use of yeast as 
an advantageous model organism in aging research greatly contributed to the current 
understanding of the molecular and cellular mechanisms underlying longevity regulation 
in evolutionarily distant eukaryotic organisms. Due to the relatively short and easily 
monitored replicative and chronological lifespans of this genetically and biochemically 
manipulable unicellular eukaryote with annotated genome, it has been successfully used 
to 1) identify numerous novel longevity genes, all of which have been later implicated in 
regulating longevity of multicellular eukaryotic organisms; 2) establish the chemical 
nature of molecular damage that causes aging and accelerates the onset of age-related 
diseases across phyla; and 3) identify several longevity-extending small molecules, all of 
which have been later shown to slow down aging, improve health, attenuate age-related 
pathologies and delay the onset of age-related diseases in eukaryotic organisms across 
phyla [6, 7, 31, 79, 134, 151 - 153]. 
 
1.5 Objectives of this Master’s thesis work  
One of the objectives of this Master’s thesis work was to use a chemical genetic high-
throughput screen to identify small molecules that can extend longevity of 
chronologically aging yeast cultured under CR conditions. Under such conditions a pro-
aging signaling network that integrates the TOR and cAMP/PKA pathways is greatly 
attenuated. We thought that the availability of such anti-aging compounds would provide 
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a potent chemical biological tool for defining of what we call the “housekeeping” 
longevity assurance pathways. We introduced the term “housekeeping longevity 
assurance pathways” to emphasize the following: 1) these pathways modulate longevity 
irrespective of the extracellular and intracellular nutrient and energy status – in contrast 
to TOR and cAMP/PKA, the two longevity signaling pathways that are “adaptable” by 
nature because they define yeast chronological lifespan only in response to certain 
changes in such status; and 2) these pathways do not overlap (or only partially overlap) 
with the adaptable TOR and cAMP/PKA pathways that in yeast are under the stringent 
control of calorie availability. 
 
Our high-throughput screen identified several bile acids as anti-aging compounds 
targeting housekeeping longevity assurance pathways. One of the objectives of this 
Master’s thesis work was to conduct pharmacophore modeling of the anti-aging potential 
of various species of bile acids under CR and non-CR conditions. 
 
Our pharmacophore modeling of the anti-aging potential of various species of bile acids 
revealed that the most hydrophobic of them, lithocholic acid (LCA), provides yeast with 
the greatest longevity benefit when calorie supply was limited. Indeed, the life-extending 
efficacy of LCA under CR exceeded that under non-CR conditions, being inversely 
proportional to the concentration of glucose in growth medium and thus in correlation 
with the extent of calorie supply limitation. 
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Unlike mammals, yeast do not synthesize bile acids. We proposed that bile acids released 
into the environment by mammals may act as interspecies chemical signals extending 
longevity of yeast species and, perhaps, of other organisms that can: 1) sense these mildly 
toxic molecules with detergent-like properties; and 2) respond to the resulting mild 
cellular damage by developing the most efficient stress protective mechanisms. 
Therefore, one of the objectives of this Master’s thesis work was 1) to analyze how LCA 
and other small anti-aging molecules (including resveratrol, caffeine and rapamycin) 
synthesized and released into the environment by one species of the organisms 
composing an ecosystem extend longevity of other species within this ecosystem; and 
then 2) to formulate a hypothesis on how these interspecies chemical signals could create 
xenohormetic, hormetic and cytostatic selective forces driving the evolution of longevity 
regulation mechanisms at the ecosystemic level. 
 
One of the objectives of this Master’s thesis work was to test the validity of the proposed 
here unified hypothesis of the xenohormetic, hormetic and cytostatic selective forces 
driving the evolution of longevity regulation mechanisms within ecosystems by carrying 
out the LCA-driven experimental evolution of long-lived yeast species. Our serial-batch-
transfer type of selection yielded three laboratory-evolved yeast strains with greatly 
extended lifespan. One of the objectives of this Master’s thesis work was to use these 
extremely long-lived yeast species for establishing the molecular mechanisms underlying 




1.6 Thesis outline and contributions of colleagues 
Chapter 2 describes our pharmacophore modeling of the anti-aging potential of various 
species of bile acids. Our data imply that the maintenance of the minimal polarity of both 
the hydrophilic (concave) and hydrophobic (convex) sides of the steroid nucleus - by 
avoiding the presence of polar substituents at the positions 6, 7 and 12 - is mandatory for 
the extreme life-extending efficacy of LCA under CR conditions. Such stringent 
structural requirements are consistent with a target specificity of LCA action as an anti-
aging small molecule. We also found that the life-extending efficacy of LCA under CR 
exceeds that under non-CR conditions, being inversely proportional to the concentration 
of glucose in growth medium and thus in correlation with the extent of calorie supply 
limitation. We therefore concluded that LCA delays aging of chronologically aging yeast 
by modulating housekeeping longevity assurance processes. Our other published data 
imply that these processes are not regulated by the adaptable TOR and cAMP/PKA 
signaling pathways. We expect that this knowledge will be instrumental for defining 
molecular mechanisms underlying the ability of LCA to extend longevity by impacting 
these various housekeeping longevity assurance processes and by modulating signaling 
pathways governing them. 
 
Chapter 3 describes our hypothesis in which interspecies chemical signals released into 
the environment create xenohormetic, hormetic and cytostatic selective forces that drive 
the ecosystemic evolution of longevity regulation mechanisms. In our hypothesis, the 
ability of a species of the organisms composing an ecosystem to undergo life-extending 
metabolic or physiological changes in response to hormetic or cytostatic chemical 
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compounds released to the ecosystem by other species: 1) increases its chances of 
survival; 2) creates selective forces aimed at maintaining such ability; and 3) enables the 
evolution of longevity regulation mechanisms. 
 
To verify empirically our hypothesis of the xenohormetic, hormetic and cytostatic 
selective forces driving the evolution of longevity regulation mechanisms at the 
ecosystemic level, in experiments described in Chapter 4 we carried out the LCA-driven 
multistep selection of long-lived yeast species under laboratory conditions. We found that 
a lasting exposure of wild-type (WT) yeast to LCA results in selection of yeast species 
that live significantly longer in the absence of this bile acid than their ancestor. Our data 
imply that the evolved under laboratory conditions long-lived yeast species 3, 5 and 12 
were able to maintain their greatly extended chronological life spans (CLS) following 
numerous successive passages in medium without LCA under CR conditions. 
Furthermore, we revealed that each of these long-lived yeast species also exhibited 
extended CLS when cultured in the absence of LCA under non-CR conditions (although 
to a lesser extent than that under CR conditions). We therefore concluded that, consistent 
with its sought-after effect on longevity regulation pathways, our LCA-driven multistep 
selection process under laboratory conditions yielded long-lived yeast species whose 
greatly delayed chronological aging was caused by the accumulation of mutant alleles 
that activate so-called housekeeping longevity assurance pathways. These housekeeping 
longevity assurance pathways modulate longevity irrespective of the number of available 
calories and do not overlap with the adaptable longevity pathways that are under the 
stringent control of calorie availability [167].  
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Chapter 5 describes the results of testing other aspects of our hypothesis on the 
ecosystemic evolution of longevity regulation mechanisms. Sprcifically, we assessed how 
a mutant allele or alleles selected during the LCA-driven multistep selection process of 
long-lived yeast species 3, 5 and 12 influence a compendium of the housekeeping 
longevity-related processes that, as we recently revealed, are modulated by LCA in 
chronologically aging yeast. We found that in the absence of LCA this allele or alleles 
alter the age-dependent dynamics of mitochondrial respiration under both CR and non-
CR conditions. Thus, consistent with its sought-after effect on longevity regulation 
pathways, our LCA-driven multistep selection process under laboratory conditions 
yielded long-lived yeast species whose greatly delayed chronological aging was caused 
by the selection of a mutant allele or alleles that activate so-called housekeeping 
longevity assurance pathways.  
 
Most of the findings described in Chapter 2 have been published in Aging [Goldberg, 
A.A., Richard, V.R., Kyryakov, P., Bourque, S.D., Beach, A., Burstein, M.T., Glebov, 
A., Koupaki, O., Boukh-Viner, T., Gregg, C., Juneau, M., English, A.M., Thomas, D.Y. 
and Titorenko, V.I. (2010). Chemical genetic screen identifies lithocholic acid as an anti-
aging compound that extends yeast chronological lifespan in a TOR-independent manner, 
by modulating housekeeping longevity assurance processes. Aging 2:393-414]. I carried 
out the pharmacophore modeling of the anti-aging potential of various species of bile 
acids and prepared the first draft of two sections relevant to my work. Dr. V. Titorenko 
provided intellectual leadership of this project and edited the manuscript.  
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Findings described in Chapter 3 have been published in Dose-Response [Burstein, M.T., 
Beach, A., Richard, V.R., Koupaki, O., Gomez-Perez, A., Goldberg, A.A., Kyryakov, P., 
Bourque, S.D., Glebov, A. and Titorenko, V.I. (2011). Interspecies chemical signals 
released into the environment may create xenohormetic, hormetic and cytostatic selective 
forces that drive the ecosystemic evolution of longevity regulation mechanisms. Dose-
Response 9: in press. I prepared the first draft of a section describing the ability of 
rapamycin released into environment to act as a cytostatic chemical signal that extends 
longevity of the other organisms within an ecosystem.  Dr. V. Titorenko provided 
intellectual leadership of this project and edited the manuscript. 
 
Findings described in Chapter 4 are presented in the manuscript of a paper [Glebov, A., 
Gomez-Perez, A., Kyryakov, P., Burstein, M.T., Beach, A., Richard, V.R. and Titorenko, 
V.I. Laboratory evolution of longevity regulation mechanisms by a lasting exposure of 
the yeast Saccharomyces cerevisiae to a bile acid] that is currently in preparation for 
submission to Current Biology. I expect this manuscript to be submitted for publication in 
the late spring or early summer of 2012. I carried out a 3-step process of the laboratory 
evolution of long-lived yeast species by a lasting exposure of wild-type yeast to  
lithocholic acid  and prepared the first draft of four sections relevant to my work. Dr. V. 
Titorenko provided intellectual leadership of this project and edited the manuscript. 
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2 Pharmacophore modeling of the anti-aging potential of bile acids  
 
2.1 Abstract 
Longevity of chronologically aging yeast can be extended by administering a caloric 
restriction (CR) diet [6, 7, 10, 24, 35, 63] or some small molecules [101, 110, 114, 134]. 
These life-extending interventions target the adaptable target of rapamycin (TOR) and 
cAMP/protein kinase A (cAMP/PKA) signaling pathways that are under the stringent 
control of calorie availability [6, 7, 10, 35, 101, 110, 114, 134]. We designed a chemical 
genetic screen for small molecules that increase the chronological life span (CLS) of 
yeast under CR by targeting lipid metabolism and modulating housekeeping longevity 
pathways that regulate longevity irrespective of the number of available calories. By 
screening the total of approximately 19,000 representative compounds from seven 
commercial libraries, we identified 24 small molecules that greatly extend the CLS of a 
short-lived mutant pex5' deficient in peroxisomal fatty acid oxidation, which we used for 
our high-throughput screen. These anti-aging small molecules belong to 5 chemical 
groups. Group I consisted of 6 bile acids, including lithocholic acid (LCA), deoxycholic 
acid (DCA), chenodeoxycholic acid (CDCA), cholic acid (CA), dehydrocholic acid 
(DHCA) and hyodeoxycholic acid (HDCA). The results of our pharmacophore modeling 
of the anti-aging potential of various species of bile acids imply that the maintenance of 
the minimal polarity of both the hydrophilic (concave) and hydrophobic (convex) sides of 
the steroid nucleus - by avoiding the presence of polar substituents at the positions 6, 7 
and 12 - is mandatory for the extreme life-extending efficacy of LCA under CR 
conditions. Such stringent structural requirements are consistent with a target specificity 
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of LCA action as an anti-aging small molecule. We found that the life-extending efficacy 
of LCA under CR exceeds that under non-CR conditions, being inversely proportional to 
the concentration of glucose in growth medium and thus in correlation with the extent of 
calorie supply limitation.  
 
2.2 Introduction 
Aging of multicellular and unicellular eukaryotic organisms is a multifactorial biological 
phenomenon that has various causes and affects a plethora of cellular activities [1 - 3, 5, 
8, 10, 24]. These numerous activities are modulated by only a few nutrient- and energy-
sensing signaling pathways that are conserved across phyla and include the 
insulin/insulin-like growth factor 1 (IGF-1), AMP-activated protein kinase/target of 
rapamycin (AMPK/TOR) and cAMP/protein kinase A (cAMP/PKA) pathways [4, 10, 
36]. By sharing a compendium of protein kinases and adaptor proteins, the insulin/IGF-1, 
AMPK/TOR and cAMP/PKA pathways in yeast, worms, fruit flies and mammals 
converge into a network regulating longevity [4, 10, 36 - 38, 154]. This network may also 
include several proteins that currently are not viewed as being in any of these three 
pathways [4, 10, 36, 73, 74]. Moreover, this network responds to the age-related partial 
mitochondrial dysfunction and is modulated by mitochondrially produced reactive 
oxygen species (ROS) [36, 73, 75, 147]. By sensing the nutritional status of the whole 
organism as well as the intracellular nutrient and energy status, functional state of 
mitochondria, and concentration of ROS produced in mitochondria, the longevity 
network regulates life span across species by coordinating information flow along its 
convergent, divergent and multiply branched signaling pathways. 
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By defining the organismal and intracellular nutrient and energy status, nutrient intake 
plays an important role in modulating life span and influences age-related pathologies [7, 
155]. Two dietary regimens are known to have the most profound life-extending effects 
across species and to improve overall health by delaying the onset of age-related diseases. 
They include: 1) caloric restriction (CR), a diet in which only calorie intake is reduced 
but the supply of amino acids, vitamins and other nutrients is not compromised [13, 76, 
77, 80, 155]; and 2) dietary restriction (DR), in which the intake of nutrients (but not 
necessarily of calories) is reduced by limiting food supply without causing malnutrition 
[66, 76, 77, 91]. In a “TOR-centric” view of longevity regulation, TOR alone governs the 
life-extending and health-improving effects of CR/DR by: 1) integrating the flow of 
information on the organismal and intracellular nutrient and energy status from the 
protein kinases AMPK, PKA, PKB/AKT (the insulin/IGF-1 pathway) and ERK1/2 (the 
PKA-inhibited Raf/MEK/ERK protein kinase cascade) as well as from the mitochondrial 
redox protein P66Shc; 2) sensing the intracellular levels of amino acids in an AMPK-
independent manner; and 3) operating as a control center which, based on the information 
it has gathered and processed, modulates many longevity-related processes in a sirtuin-
independent fashion [84 - 86]. The inability of CR to increase the replicative life span 
(RLS) of yeast mutants lacking components of the TOR pathway [87] and the lack of the 
beneficial effect of DR on life span in worms with reduced TOR signaling [88, 89] 
support the proposed central role for TOR in orchestrating the life-extending effect of 
CR/DR in these two longevity paradigms. Moreover, while the postulated by the TOR-
centric model dispensability of sirtuins for the longevity benefit associated with DR has 
been confirmed in worms [89], the importance of the sirtuin Sir2p in mediating the life-
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extending effect of CR in replicatively aging yeast is debated [56, 87, 145, 151]. 
Noteworthy, while TOR is a central regulator of the life-extending effect of CR in 
replicatively aging yeast, the longevity benefit associated with CR in chronologically 
aging yeast is mediated by a signaling network that includes: 1) the TOR and cAMP/PKA 
pathways converged on Rim15p, which therefore acts as a nutritional integrator; and 2) 
some other, currently unknown pathways that are not centered on Rim15p [154]. 
Considering the likely convergence of the insulin/IGF-1, AMPK/TOR and cAMP/PKA 
signaling pathways into a network regulating longevity in worms, fruit flies and 
mammals (see above), it is conceivable that - akin to TOR - the insulin/IGF-1 and 
cAMP/PKA pathways may contribute to the beneficial effect of CR/DR on their 
longevity. Although some findings in worms, fruit flies and mammals support the 
involvement of the insulin/IGF-1 pathway in the longevity benefit associated with 
CR/DR, other data imply that such benefit is independent of insulin/IGF-1 (reviewed by 
Narasimhan et al. [36]). The role of cAMP/PKA signaling in the life-extending effect of 
CR/DR in these multicellular eukaryotes remains to be tested. Importantly, the recently 
reported in worms involvement of both independent and overlapping pathways in life 
span extension by different DR regimens [100] supports the notion that the longevity 
benefit associated with nutrient limitation is mediated by a signaling network that 
integrates several pathways.  
             
Akin to CR and DR regimens, certain pharmacological interventions can extend 
longevity across phyla and improve health by beneficially influencing age-related 
pathologies. Noteworthy, all of the currently known anti-aging compounds increase life 
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span under non-CR or non-DR conditions (see chapter 1 of my thesis for a detailed 
discussion of this topic). Under such conditions, these compounds have been shown to: 1) 
provide the longevity and health benefits associated with CR and DR, but without 
restricting caloric and nutrient intake; and 2) mimic numerous life-extending effects of 
CR and DR on gene expression pattern, metabolic and physiological processes, and stress 
response pathways. Therefore, the names “CR mimetics” and “DR mimetics” have been 
coined for them [149, 150]. Importantly, most CR mimetics and DR mimetics target 
signaling pathways that modulate longevity in response to the organismal and 
intracellular nutrient and energy status, including the insulin/IGF-1 and AMPK/TOR 
pathways as well as the sirtuin-governed protein deacetylation module of the longevity 
signaling network integrating these pathways (see chapter 1 of my thesis for a detailed 
discussion of this topic). Furthermore, such compounds as resveratrol, metformin and 
mianserin increase life span only under non-CR or non-DR conditions, but are unable to 
do so if the supply of calories or nutrients is limited [107, 112, 119 - 121]. Hence, one 
could envision that most, if not all, longevity pathways are “adaptable” by nature, i.e., 
that they modulate longevity only in response to certain changes in the extracellular and 
intracellular nutrient and energy status of an organism. However, Li+ in worms and 
rapamycin in fruits flies extend life span even under DR conditions [103, 113]. It is likely 
therefore that some longevity pathways could be “constitutive” or “housekeeping” by 
nature, i.e., that they: 1) modulate longevity irrespective of the organismal and 
intracellular nutrient and energy status; and 2) do not overlap (or only partially overlap) 
with the adaptable longevity pathways that are under the stringent control of calorie 
and/or nutrient availability. The challenge is to identify such housekeeping longevity 
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pathways, perhaps by using a chemical screen for compounds that can extend longevity 
even under CR/DR conditions. Because under such conditions the adaptable pro-aging 
pathways are fully suppressed and the adaptable anti-aging pathways are fully activated, 
a compound that can increase life span is expected to target the housekeeping longevity 
pathways.  
             
Noteworthy, two anti-aging compounds alter lipid levels in mammals and fruit flies under 
non-DR conditions. In fact, resveratrol treatment reduces the levels of the neutral lipids 
triacylglycerols (TAG) and increases free fatty acid (FFA) levels in mouse adipocytes 
[127]. Furthermore, feeding rapamycin to fruit flies results in elevated TAG levels [113]. 
Although it remains to be seen if such effects of resveratrol and rapamycin on lipid levels 
play a casual role in their anti-aging action under non-DR conditions, it should be 
stressed that lipid metabolism has been shown to be involved in longevity regulation in 
yeast [24, 156], worms [50, 74, 157, 158], fruit flies [157, 159] and mice [127, 157, 160 - 
163]. Recently, our laboratory proposed a mechanism linking yeast longevity and lipid 
dynamics in the endoplasmic reticulum (ER), lipid bodies and peroxisomes. In this 
mechanism, a CR diet extends yeast CLS by activating FFA oxidation in peroxisomes 
[24, 156]. It is conceivable that the identification of small molecules targeting this 
mechanism could yield novel anti-aging compounds. Such compounds can be used as 
research tools for defining the roles for different longevity pathways in modulating lipid 
metabolism and in integrating lipid dynamics with other longevity-related processes. 
Furthermore, the availability of such compounds would enable a quest for housekeeping 
longevity assurance pathways that do not overlap (or only partially overlap) with the 
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adaptable TOR and cAMP/PKA pathways. Moreover, such compounds would have a 
potential to be used as pharmaceutical agents for increasing life span and promoting 
healthy aging by delaying the onset of age-related diseases, regardless of an organism’s 
dietary regimen. 
             
We sought to identify small molecules that increase the CLS of yeast under CR 
conditions by targeting lipid metabolism and modulating housekeeping longevity 
assurance pathways. Our chemical genetic screen identified bile acids as one of the 5 
chemical groups of such anti-aging small molecules. Our pharmacophore modeling of the 
anti-aging potential of various species of bile acids under CR and non-CR conditions 
provided important new insights into mechanisms of longevity regulation, as outlined 
below.  
 
2.3 Materials and Methods 
Strains and media  
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) was used in this study. Media components were as follows: 1) YEPD (0.2% 
Glucose), 1% yeast extract, 2% peptone, 0.2% glucose; 2) YEPD (0.5% Glucose), 1% 
yeast extract, 2% peptone, 0.5% glucose; 3) YEPD (1% Glucose), 1% yeast extract, 2% 





A plating assay for the analysis of chronological life span (CLS) 
Cells were grown in YEPD medium initially containing 0.2%, 0.5%, 1% or 2% glucose 
as carbon source at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a 
flask volume/medium volume ratio of 5:1. A sample of cells was removed from each 
culture at various time points. A fraction of the cell sample was diluted in order to 
determine the total number of cells per ml of culture using a hemacytometer. 10 Pl of 
serial dilutions (1:10 to 1:103) of cells were applied to the hemacytometer, where each 
large square is calibrated to hold 0.1 Pl. The number of cells in 4 large squares was then 
counted and an average was taken in order to ensure greater accuracy. The concentration 
of cells was calculated as follows: number of cells per large square x dilution factor × 10 
× 1,000 = total number of cells per ml of culture. A second fraction of the cell sample 
was diluted and serial dilutions (1:102 to 1:105) of cells were plated onto YEPD (2% 
Glucose) plates in triplicate in order to count the number of viable cells per ml of each 
culture. 100 Pl of diluted culture was plated onto each plate. After a 48-h incubation at 
30oC, the number of colonies per plate was counted. The number of colony forming units 
(CFU) equals to the number of viable cells in a sample. Therefore, the number of viable 
cells was calculated as follows: number of colonies × dilution factor × 10 = number of 
viable cells per ml. For each culture assayed, % viability of the cells was calculated as 
follows: number of viable cells per ml / total number of cells per ml × 100%. The % 





Pharmacological manipulation of CLS 
CLS analysis was performed as described above in this section. The chenodeoxycholic 
(C9377), cholic (C1129), dehydrocholic (D3750), deoxycholic (D2510), hyodeoxycholic 
(H3878), lithocholic (L6250) and ursodeoxycholic (U5127) bile acids were from Sigma. 
Their stock solutions in DMSO were made on the day of adding each of these compounds 
to cell cultures. Compounds were added to growth medium at the indicated concentration 
immediately following cell inoculation. The final concentration of DMSO in yeast 
cultures supplemented with a bile acid (and in the corresponding control cultures 




2.4.1 Pharmacophore modeling of the anti-aging potential of bile acids 
To perform a chemical genetic screen for small molecules that increase the CLS of yeast 
by targeting lipid metabolism, we chose the single-gene-deletion mutant strain pex5'. 
Because pex5' lacks a cytosolic shuttling receptor for peroxisomal import of Fox1p and 
Fox2p, these two enzymes of the β-oxidation of free fatty acids (FFA) reside in the 
cytosol of pex5' cells [164]. In contrast, the Pex5p-independent peroxisomal import of 
Fox3p, the third enzyme of the FFA β-oxidation pathway, sorts it to the peroxisome in 
pex5' cells [164]. By spatially separating Fox1p and Fox2p from Fox3p within a cell, the 
pex5' mutation impairs FFA oxidation. In chronologically aging yeast grown under CR 
conditions on 0.2% or 0.5% glucose, peroxisomal FFA oxidation regulates longevity by 
1) efficiently generating acetyl-CoA to synthesize the bulk of ATP in mitochondria; and 
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2) acting as a rheostat that modulates the age-related dynamics of FFA and diacylglycerol 
(DAG), two regulatory lipids known to promote longevity-defining cell death [24, 156, 
165, 166]. Unlike CR yeast, chronologically aging non-CR yeast grown on 1% or 2% 
glucose are unable to generate significant quantities of ATP by oxidizing peroxisome-
derived acetyl-CoA in mitochondria and, instead, produce the bulk of ATP via glycolytic 
oxidation of glycogen- and trehalose-derived glucose [24, 156, 165]. Consistent with the 
essential role of peroxisomal FFA oxidation as a longevity assurance process only under 
CR, the pex5' mutation substantially shortened the CLS of CR yeast but caused a 
significantly lower reduction of longevity in non-CR yeast, especially in yeast grown on 
2% glucose [167]. Our published data imply that, by impairing peroxisomal FFA 
oxidation and affecting lipid metabolism in the endoplasmic reticulum (ER) and lipid 
bodies, the pex5' mutation alters the levels of numerous pro- and anti-aging proteins and 
impacts many longevity-related processes, thereby shortening the CLS of yeast when 
calorie supply is limited [167]. We therefore chose the short-lived pex5' strain to carry 
out a chemical genetic screen for anti-aging compounds that target lipid metabolism to 
extend CLS in yeast placed on a CR diet. By screening the total of approximately 19,000 
representative compounds from seven commercial libraries, we identified 24 small 
molecules that greatly extend the CLS of pex5' under CR and belong to 5 chemical 
groups. Group I consisted of 6 bile acids, including lithocholic acid (LCA), deoxycholic 
acid (DCA), chenodeoxycholic acid (CDCA), cholic acid (CA), dehydrocholic acid 
(DHCA) and hyodeoxycholic acid (HDCA).  
 
 39 
Our pharmacophore modeling of the anti-aging potential of various species of bile acids 
revealed that some of them extended the CLS of wild-type (WT) strain under CR 
conditions. Specifically, we found that LCA and two other bile acids - DCA and CDCA - 
increased both the mean and maximum CLS of WT yeast grown under CR on 0.2% 
glucose (Figures 2.1A to 2.1D). Moreover, DHCA increased only the mean CLS of WT 
yeast under CR at 0.2% glucose, whereas HDCA increased only their maximum CLS 
(Figures 2.1A to 2.1D). The most hydrophobic bile acid, LCA [168], provided WT cells 
with the greatest longevity benefit when calorie supply was limited. In fact, we found that 
LCA increased the mean CLS of WT strain under CR at 0.2% glucose by almost 250% 
and its maximum CLS by more than 200% (Figures 2.1A - 2.1D). Our comparative 
analysis of the structural differences between various bile acids and their relative life-
extending efficacies revealed that the positions 6, 7 and 12 in the six-member rings B and 
C of the steroid nucleus are important for the anti-aging potential of a bile acid. Indeed, 
the ability of LCA to extend both the mean and maximum CLS of WT yeast under CR 
can be: 1) eliminated (with respect to the mean CLS) or greatly reduced (with respect to 
the maximum CLS) by attaching an α-oriented hydroxyl group at the position 6 (as in 
HDCA); 2) greatly reduced (with respect to both the mean and maximum CLS) by 
attaching an α-oriented hydroxyl group at the position 7 (as in CDCA); and 3) greatly 
reduced (with respect to both the mean and maximum CLS) by attaching an α-oriented 
hydroxyl group at the position 12 (as in DCA) (Figures 2.1B to 2.1E). All these 
modifications to the structure of LCA increase polarity of the hydrophilic (concave) side 
[α-face] of the steroid nucleus by positioning a hydroxyl group below the nucleus and 
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Figure 2.1. LCA and some other bile acids extend the CLS of WT strain under CR 
conditions. (A - D) Effect of various bile acids on survival (A) and on the mean and 
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maximum life spans (B - D) of chronologically aging WT strain grown under CR 
conditions on 0.2% glucose. Data are presented as means ± SEM (n = 3-28; ***p < 
0.001; **p < 0.01; *p < 0.05). (E) Structure and hydrophilic/hydrophobic properties of 
bile acids. The R1 (α), R3 (α) and R5 (α) hydroxyl groups at the positions 6, 7 and 12 in 
the six-member rings B and C of the steroid nucleus increase polarity of the hydrophilic 
(concave) side [α-face] of the nucleus by being located below the nucleus and axially to 
its plane. The R4 (β) hydroxyl group at the position 7 in the six-member ring B of the 
steroid nucleus confers polarity of the hydrophobic (convex) side [β-face] of the nucleus 
by being located above the nucleus and equatorially to its plane.  
 
abolished by attaching a β-oriented hydroxyl group at the position 7 (as in UDCA), 
thereby conferring polarity to the hydrophobic (convex) side [β-face] of the steroid 
nucleus by positioning a hydroxyl group above the nucleus and equatorially to its plane 
(Figures 2.1B to 2.1E). Moreover, the simultaneous attachments of two α-oriented 
hydroxyl groups (as in CA) or two keto groups (as in DHCA) at the positions 7 and 12 
eliminated the ability of LCA to extend both the mean and maximum CLS of WT yeast 
under CR (Figures 2.1B to 2.1E).  
 
Altogether, the results of our pharmacophore modeling of the anti-aging potential of bile 
acids imply that the maintenance of the minimal polarity of both the hydrophilic 
(concave) and hydrophobic (convex) sides of the steroid nucleus - by avoiding the 
presence of polar substituents at the positions 6, 7 and 12 - is mandatory for the extreme 
life-extending efficacy of LCA under CR conditions. Such stringent structural 




2.4.2 LCA extends the CLS of WT yeast under both CR and non-CR conditions, 
although to a different extent 
We found that, if added to growth medium at the time of cell inoculation, LCA increased 
both the mean and maximum CLS of WT strain not only under CR at 0.2% or 0.5% 
glucose (Figures 2.2A, 2.2B and 2.2G – 2.2I) but also under non-CR conditions 
administered by culturing yeast in medium initially containing 1% or 2% glucose 
(Figures 2.2C, 2.2D and 2.2G – 2.2I). At any tested concentration of glucose in growth 
medium, LCA displayed the greatest beneficial effect on both the mean and maximum 
CLS of WT strain if used at a final concentration of 50 μM (Figures 2.2E and 2.2F). It 
should be stressed that the life-extending efficacy of 50 μM LCA under CR exceeded that 
under non-CR conditions, being inversely proportional to the concentration of glucose in 
growth medium and thus in correlation with the extent of calorie supply limitation 
(Figures 2.2G to 2.2I). Importantly, although 50 μM LCA displayed a profound effect on 
CLS, it did not cause significant changes in growth of WT strain at any tested 
concentration of glucose in medium. In fact, we found that both growth rate in 
logarithmic phase and time prior to entry into stationary (ST) phase were similar for WT 
cells cultured in medium with or without LCA (Figure 2.3). 
 
2.5 Discussion 
In studies described in this chapter, we carried out a high-throughput chemical genetic 
screen for small molecules that increase the CLS of yeast under CR conditions by 
targeting lipid metabolism and modulating housekeeping longevity pathways that 
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Figure 2.2. In chronologically aging WT yeast, the life-extending efficacy of LCA under 
CR exceeds that under non-CR conditions. (A - F) Effect of various concentrations of 
LCA on survival (A - D) and on the fold increase in the mean (E) or maximum (F) life 
span of chronologically aging WT strain cultured in medium initially containing 0.2%, 
0.5%, 1% or 2% glucose. Data are presented as means ± SEM (n = 3-28). (G - I) Effect of 
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50 μM LCA on the mean or maximum CLS of WT yeast cultured in medium initially 
containing 0.2%, 0.5%, 1% or 2% glucose. Data are presented as means ± SEM (n = 12-























































































Figure 2.3. LCA does not cause significant changes in growth pattern of wild-type (WT) 
strain at any tested concentration of glucose in medium. Kinetics of growth for WT strain 
in medium initially containing 0.2%, 0.5%, 1.0% or 2.0% glucose in the presence of LCA 
(50 μM ) or in its presence. Each plot shows a representative experiment repeated 4-7 
times in triplicate with similar results. Abbreviations: D, diauxic growth phase; L, 
logarithmic growth phase; PD, post-diauxic growth phase; ST, stationary growth phase. 
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of approximately 19,000 representative compounds from seven commercial libraries, we 
identified bile acids as one of the five chemical groups of such anti-aging small 
molecules. The results of our pharmacophore modeling of the anti-aging potential of 
various species of bile acids imply that the maintenance of the minimal polarity of both 
the hydrophilic (concave) and hydrophobic (convex) sides of the steroid nucleus - by 
avoiding the presence of polar substituents at the positions 6, 7 and 12 - is mandatory for 
the extreme life-extending efficacy of LCA under CR conditions. Such stringent 
structural requirements are consistent with a target specificity of LCA action as an anti-
aging small molecule. We also found that the life-extending efficacy of LCA under CR 
exceeds that under non-CR conditions, being inversely proportional to the concentration 
of glucose in growth medium and thus in correlation with the extent of calorie supply 
limitation. We therefore concluded that LCA delays aging of chronologically aging yeast 
by modulating housekeeping longevity assurance processes. Our other published data 
imply that these processes are not regulated by the adaptable TOR and cAMP/PKA 
signaling pathways [167].  
 
Noteworthy, although we found that LCA greatly extends yeast longevity, yeast do not 
synthesize this or any other bile acid found in mammals [168, 169]; a recent mass 
spectrometry-based analysis of the total yeast lipidome conducted by Simon Bourque and 
Adam Beach in Dr. Titorenko’s laboratory has confirmed lack of endogenous bile acids. 
One could envision that during evolution yeast have lost the ability to synthesize bile 
acids but have maintained the life-extending response to these biologically active 
molecules by retaining certain longevity-related processes that are sensitive to regulation 
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by bile acids. Alternatively, one could think that during evolution yeast have developed 
the ability to sense bile acids produced by mammals (and/or bile acid-like lipids 
synthesized by worms), recognize these mildly toxic molecules as environmental 
stressors providing hormetic benefits and/or as indicators of the state of the environment 
or food supply, and then to respond by undergoing certain life-extending changes to their 
physiology that ultimately increase their chances of survival. It is conceivable therefore 
that the life-extending potential of LCA and other bile acids as well as, probably, the 
mechanisms underlying their anti-aging action are evolutionarily conserved.  
             
In fact, following their synthesis from cholesterol in the intestine, hypodermis, 
spermatheca and sensory neurons of worms, bile acid-like dafachronic acids (including 3-
keto-LCA) have been shown to be delivered to other tissues where they activate the 
DAF-12/DAF-16 signaling cascade that in turn orchestrates an anti-aging transcriptional 
program, thereby increasing the life span of the entire organism [157]. Bile acids also 
provide health benefits to mammals. Synthesized from cholesterol in hepatocytes of the 
liver, these amphipathic molecules have been for a long time considered to function only 
as trophic factors for the enteric epithelium and as detergents for the emulsification and 
absorption of dietary lipids and fat-soluble vitamins [168 - 170]. Recent years have been 
marked by a significant progress in our understanding of the essential role that bile acids 
play as signaling molecules regulating lipid, glucose and energy homeostasis and 
activating detoxification of xenobiotics [168, 170, 171]. By stimulating the G-protein-
coupled receptor TGR5, bile acids activate the cAMP/PKA signaling pathway that 1) 
enhances energy expenditure in brown adipose tissue and muscle by stimulating 
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mitochondrial oxidative phosphorylation and uncoupling; 2) improves liver and 
pancreatic function by activating the endothelial nitric oxide synthase; and 3) enhances 
glucose tolerance in obese mice by inducing intestinal glucagon-like peptide-1 release 
[168, 170, 171]. Furthermore, by activating the farnesoid X receptor (FXR) and several 
other nuclear hormone receptors inside mammalian cells, bile acids 1) modulate the 
intracellular homeostasis of cholesterol, neutral lipids and fatty acids; 2) regulate glucose 
metabolism by enhancing glycogenesis and attenuating gluconeogenesis; and 3) stimulate 
clearance of xenobiotic and endobiotic toxins by activating transcription of numerous 
xenobiotic detoxification genes [168 - 172]. All these health-improving, beneficial 
metabolic effects of bile acids prevent the development of obesity following 
administration of high-fat diet [168 - 170]. Thus, bile acids have a great potential as 
pharmaceutical agents for the treatment of diabetes, obesity and various associated 
metabolic disorders, all of which are age-related [168, 169]. Moreover, bile acids have 
been shown to inhibit neuronal apoptosis in experimental rodent models of 
neurodegenerative disorders by promoting mitochondrial membrane stability, preventing 
the release of cytochrome c from mitochondria,  reducing activities of various caspases, 
and activating the NF-κB, PI3K and MAPK survival pathways [172, 173]. 
             
It should be emphasized that many of the metabolic, stress response and apoptotic 
processes modulated by bile acids in mammals are essential for healthy aging and 
longevity regulation. Importantly, we found that, by modulating several of these health- 
and longevity-related processes in chronologically aging yeast, LCA increases their life 
span [167]. Moreover, the long-lived Ghrhrlit/lit mice displayed elevated levels of several 
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bile acids and exhibited increased FXR-dependent transcription of numerous xenobiotic 
detoxification genes; if administered to food consumed by wild-type mice, cholic acid - 
one of these bile acids - mimicked the FXR-governed gene expression pattern observed 
in Ghrhrlit/lit mice [174, 175]. It has been therefore proposed that, by promoting chemical 
hormesis in mammals, these mildly toxic molecules with detergent-like properties may 
extend their longevity by acting as endobiotic regulators of aging [175 - 177]. 
             
Altogether, these findings support the notion that bile acids act as endobiotic and 
xenobiotic regulators of aging that are beneficial to health and longevity across phyla. 
Our comparative analysis of the mechanisms underlying such health-improving and life-




Our high-throughput chemical genetic screen identified LCA, a bile acid, as a novel anti-
aging compound that extends yeast chronological life span under CR conditions by 
targeting lipid metabolism and modulating housekeeping longevity assurance pathways. 
The results of our pharmacophore modeling of the anti-aging potential of various species 
of bile acids imply that the maintenance of the minimal polarity of both the hydrophilic 
(concave) and hydrophobic (convex) sides of the steroid nucleus is mandatory for the 
extreme life-extending efficacy of LCA under CR conditions. Such stringent structural 
requirements are consistent with a target specificity of LCA action as an anti-aging small 
molecule. Moreover, we found that the life-extending efficacy of LCA under CR exceeds 
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that under non-CR conditions, being inversely proportional to the concentration of 
glucose in growth medium and thus in correlation with the extent of calorie supply 
limitation. We therefore concluded that LCA delays aging of chronologically aging yeast 
by modulating housekeeping longevity assurance processes. Our other published data 
imply that these processes are not regulated by the adaptable TOR and cAMP/PKA 
signaling pathways. We expect that this knowledge will be instrumental for defining 
molecular mechanisms underlying the ability of LCA to extend longevity by impacting 
these various housekeeping longevity assurance processes and by modulating signaling 








3 Interspecies chemical signals released into the environment may create 
xenohormetic, hormetic and cytostatic selective forces that drive the 




In our recent chemical genetic screen, we identified lithocholic acid (LCA) as a novel 
anti-aging molecule that extends yeast longevity. Yeast do not synthesize this or any 
other bile acids produced by mammals [168, 169]; a recent mass spectrometry-based 
analysis of the total yeast lipidome conducted in Dr. Titorenko’s laboratory has 
confirmed lack of endogenous bile acids. Noteworthy, various organisms (i.e., bacteria, 
fungi, plants and animals) within an ecosystem can synthesize and release into the 
environment certain longevity-extending small molecules. In this chapter, we hypothesize 
that these interspecies chemical signals can create xenohormetic, hormetic and cytostatic 
selective forces driving the ecosystemic evolution of longevity regulation mechanisms. In 
our hypothesis, following their release into the environment by one species of the 
organisms composing an ecosystem, such small molecules can activate anti-aging 
processes and/or inhibit pro-aging processes in other species within the ecosystem. The 
organisms that possess the most effective (as compared to their counterparts of the same 
species) mechanisms for sensing the chemical signals produced and released by other 
species and for responding to such signals by undergoing certain hormetic and/or 
cytostatic life-extending changes to their metabolism and physiology are expected to live 
longer than their counterparts within the ecosystem. We therefore propose that the ability 
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of a species of the organisms composing an ecosystem to undergo life-extending 
metabolic or physiological changes in response to hormetic or cytostatic chemical 
compounds released to the ecosystem by other species: 1) increases its chances of 
survival; 2) creates selective forces aimed at maintaining such ability; and 3) enables the 
evolution of longevity regulation mechanisms. 
 
3.2 Introduction 
Aging of multicellular and unicellular eukaryotic organisms is a highly complex 
biological phenomenon, which affects numerous processes within cells [178 - 181]. 
These cellular processes include cell cycle, cell growth, stress response, protein folding, 
apoptosis, autophagy, proteasomal protein degradation, actin organization, signal 
transduction, nuclear DNA replication, chromatin assembly and maintenance, ribosome 
biogenesis and translation, lipid and carbohydrate metabolism, oxidative metabolism in 
mitochondria, NAD+ homeostasis, amino acid biosynthesis and degradation, and 
ammonium and amino acid uptake [182 - 186]. Across phyla, such plethora of longevity-
defining processes is governed by a nutrient signaling network integrating the AMP-
activated protein kinase/target of rapamycin (AMPK/TOR), cAMP/protein kinase A 
(cAMP/PKA) and insulin/insulin-like growth factor 1 (IGF-1) pathways, as well as a 
sirtuin-governed protein deacetylation module [179, 182, 184, 187 – 189]. Because this 
evolutionarily conserved signaling network regulates longevity only in response to 
certain changes in the organismal and intracellular nutrient and energy status, it is 
“adaptable” by its nature [167]. By altering the organismal and intracellular nutrient and 
energy status, caloric restriction (CR) and dietary restriction (DR) extend longevity and 
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improve health across species by modulating the adaptable longevity network [179, 190 - 
194]. Unlike signaling pathways and sirtuin-governed protein deacetylation module 
integrated into the adaptable longevity network, some longevity-defining pathways are 
“constitutive” or “housekeeping” by their nature as they regulate longevity irrespective of 
the organismal and intracellular nutrient status [167]. 
 
It should be stressed that both adaptable and housekeeping longevity pathways are the 
targets of longevity-extending and health-improving small molecules that are produced 
and then released into the environment by various organisms (i.e., bacteria, fungi, plants 
and animals) within an ecosystem. We therefore propose a hypothesis in which 
interspecies chemical signals released into the environment create xenohormetic, 
hormetic and cytostatic selective forces that empower the ecosystemic evolution of 
longevity regulation mechanisms. 
 
3.3 Hypothesis 
3.3.1 Plants and other autotrophs release into the environment xenohormetic and 
cytostatic interspecies chemical signals that extend longevity of other 
organisms within an ecosystem 
According to the “xenohormesis” hypothesis of Howitz and Sinclair, in response to 
various hormetic environmental stresses - such as UV light, dehydration, infection, 
predation, cellular damage and nutrient deprivation - plants and other autotrophic 
organisms synthesize a group of secondary metabolites called xenohormetic 
phytochemicals [195 - 197]. Prior to being released into the environment, these secondary 
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metabolites activate defense systems protecting the host autotrophic organisms against 
hormetic environmental stresses that caused their synthesis [196, 197]. After being 
released into the environment, these xenohormetic phytochemicals provide benefits to 
health and longevity of heterotrophic organisms within the ecosystem. It was proposed 
that xenohormetic phytochemicals cause such life-extending and health-improving effects 
not by operating as mildly toxic hormetic molecules, but by activating the key enzymes 
of stress-response, anti-aging pathways known to govern longevity-related processes in 
heterotrophic organisms [195 - 197]. Recent studies revealed that some xenohormetic 
phytochemicals, such as resveratrol and caffeine, extend longevity of heterotrophic 
organisms by attenuating the adaptable TOR signaling pathway known to accelerate their 
aging [198 - 202]. Because the TOR pathway also plays a pivotal role in promoting 
proliferative growth of all heterotrophic organisms, resveratrol and caffeine exhibit a 
cytostatic effect in these organisms [201 - 204].  
           
By extending the xenohormesis hypothesis of Howitz and Sinclair, we propose that 
within each of the heterotrophic species composing an ecosystem there are organisms that 
1) possess the most effective (as compared to their counterparts of the same species) 
mechanisms for sensing xenohormetic and cytostatic phytochemicals released into the 
environment by autotrophic species; and 2) can respond to these phytochemicals by 
activating the key enzymes of stress-response, anti-aging pathways and/or by attenuating 
the adaptable, pro-aging TOR signaling pathway - thereby undergoing life-extending 
changes to their metabolism and physiology. These heterotrophic organisms are expected 
to live longer than their counterparts within the same species. Thus, their ability to sense 
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the longevity-extending xenohormetic and cytostatic phytochemicals released into the 
environment by autotrophic species and to respond to these phytochemicals by 
undergoing certain life-extending metabolic and physiological changes will: 1) increase 
their chances of survival; 2) create selective forces aimed at maintaining such ability; and 
3) power the evolution of their longevity regulation mechanisms. 
 
3.3.2 Mammals release into the environment bile acids, hormetic interspecies 
chemical signals that extend longevity of yeast and perhaps of other 
organisms within an ecosystem 
In mammals, bile acids operate not only as trophic factors for the enteric epithelium and 
detergents for the emulsification and absorption of dietary lipids, but also as signaling 
molecules regulating lipid, glucose and energy homeostasis and activating detoxification 
of xenobiotics [205 - 210]. Bile acids have been shown to cause numerous health-
improving metabolic effects in mammals and to protect them from xenobiotic toxins [205 
- 210]. Therefore, it was proposed that by promoting chemical hormesis in mammals, bile 
acids – mildly toxic molecules with detergent-like properties – may extend their 
longevity by acting as endobiotic regulators of aging [211 - 214]. 
 
Importantly, our recent study identified lithocholic acid, a bile acid, as an anti-aging 
compound that extends yeast longevity by activating a compendium of anti-aging 
processes and attenuating a distinct set of pro-aging processes [167]. Unlike mammals, 
yeast do not synthesize bile acids [167, 209, 215]. We therefore propose that bile acids 
released into the environment by mammals may act as interspecies chemical signals 
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extending longevity of yeast species and, perhaps, of other organisms that can: 1) sense 
these mildly toxic molecules with detergent-like properties; and 2) respond to the 
resulting mild cellular damage by developing the most efficient stress protective 
mechanisms. We hypothesize that such mechanisms may provide effective protection of 
yeast and other organisms not only against cellular damage caused by bile acids but also 
against molecular and cellular damage accumulated with age. Thus, those species of the 
organisms within an ecosystem that that have been selected for the most effective (as 
compared to their counterparts of the same species) mechanisms providing protection 
against bile acids are expected to 1) live longer than their counterparts within the same 
species; and 2) evolve the most effective anti-aging mechanisms that are sensitive to 
regulation by bile acids. Thus, the ability of certain non-mammalian species within an 
ecosystem to sense bile acids produced by mammals and then to respond by undergoing 
certain longevity-extending changes to their physiology will increase their chances of 
survival - thereby creating selective force aimed at maintaining such ability and driving 
the evolution of their longevity regulation mechanisms.  
 
3.3.3 Soil bacteria release into the environment rapamycin, a cytostatic 
interspecies chemical signal that extends longevity of other organisms within 
an ecosystem   
The adaptable TOR signaling pathway can be attenuated not only by resveratrol and 
spermidine - the two longevity-extending xenohormetic and cytostatic phytochemicals 
released into the environment by autotrophic species – but also by rapamycin [203, 216, 
217]. Rapamycin - a macrocyclic lactone synthesized by soil bacteria to inhibit growth of 
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fungal competitors - extends longevity of yeast, fruit flies and mice by specifically 
inhibiting the nutrient-sensory protein kinase TOR, a master negative regulator of the 
pro-aging TOR signaling pathway [203, 217 - 220]. 
 
Rapamycin exhibits a potent cytostatic effect by causing G1 cell cycle arrest and greatly 
delaying proliferative growth of organisms across phyla [203, 216 - 218]. We therefore 
hypothesize that rapamycin released into the environment by soil bacteria not only 
suppresses growth of fungal competitors, but may also may create selective pressure for 
the evolution of yeast, fruit fly and mammalian species that can respond to rapamycin-
induced growth retardation by developing certain mechanisms aimed at such remodeling 
of their anabolic and catabolic processes that would increase their chances of survival 
under conditions of slow growth. We propose that some of these mechanisms delay aging 
by optimizing essential longevity-related processes and remain sensitive to modulation by 
rapamycin. Therefore, the ability of yeast, fruit fly and mammalian species composing an 
ecosystem to undergo life-extending metabolic or physiological changes in response to 
rapamycin produced by soil bacteria will: 1) increase their chances of survival; 2) create 
selective forces aimed at maintaining such ability; and 3) empower the evolution of 
longevity regulation mechanisms. 
 
3.3.4 A hypothesis of the xenohormetic, hormetic and cytostatic selective forces 
that drive the ecosystemic evolution of longevity regulation mechanisms 
Our analysis of how several small molecules synthesized and released into the 
environment by one species of the organisms composing an ecosystem extend longevity 
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of other species within this ecosystem suggests a hypothesis in which these interspecies 
chemical signals create xenohormetic, hormetic and cytostatic selective forces that impel 
the ecosystemic evolution of longevity regulation mechanisms. In our hypothesis, after 
being released into the environment by one species of organisms capable of synthesizing 
such small molecules, they can activate anti-aging processes and/or inhibit pro-aging 
processes in other species within an ecosystem (Figure 3.1). Within each of these other 
species, there are organisms that possess the most effective (as compared to their 
counterparts of the same species) mechanisms for sensing the interspecies chemical 
signals and for responding to such signals by undergoing certain life-extending changes 
to their metabolism and physiology; such life-extending changes could be hormetic 
and/or cytostatic by their nature. These organisms therefore are expected to live longer 
than their counterparts of the same species within the ecosystem. Thus, the ability of a 
species of the organisms composing an ecosystem to sense the longevity-modulating 
interspecies chemical signals released into the environment by other species within the 
ecosystem and to respond to these signals by undergoing certain life-extending metabolic 
and physiological changes is expected to increase its chances to survive, thereby creating 
selective force aimed at maintaining such ability.  
 
Our hypothesis implies that the evolution of longevity regulation mechanisms in each 
species of the organisms composing an ecosystem is driven by the ability of this species 
to undergo specific life-extending metabolic or physiological changes in response to 
hormetic or cytostatic chemical compounds that are released to the ecosystem by other 
species (Figure 3.1). 
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Figure 3.1. The xenohormetic, hormetic and cytostatic selective forces may drive the 
evolution of longevity regulation mechanisms within an ecosystem. We propose that 
organisms from all domains of life within an ecosystem synthesize chemical compounds 
that 1) are produced and then released into the environment permanently or only in 
response to deteriorating environmental conditions, increased population density of 
competitors and/or predators, or changes in food availability and its nutrient and/or 
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caloric content; 2) are mildly toxic compounds that trigger a hormetic response in an 
organism that senses them or, alternatively, are not toxic for any organism within the 
ecosystem and do not cause a hormetic response; 3) are cytostatic compounds that 
attenuate the TOR-governed signaling network or, alternatively, do not modulate this 
growth-promoting network; and 4) extend longevity of organisms that can sense these 
compounds (red arrows), thereby increasing their chances of survival and creating 
selective force aimed at maintaining the ability of organisms composing the ecosystem to 
respond to these compounds by undergoing specific life-extending changes to their 
physiology. In our hypothesis, the evolution of longevity regulation mechanisms in each 
group of the organisms composing an ecosystem is driven by the ability of this group of 
organisms to undergo specific life-extending changes to their physiology in response to a 
compendium of “critical” chemical compounds that are permanently or transiently 
released to the ecosystem by other groups of organisms. Abbreviations: LCA, lithocholic 
acid; DCA, bile acid-like dafachronic acids. 
 
3.4 Conclusions 
Our analysis of how LCA and other small anti-aging molecules (including resveratrol, 
caffeine and rapamycin) synthesized and released into the environment by one species of 
the organisms composing an ecosystem extend longevity of many other species within 
this ecosystem let us to propose a unified hypothesis of the xenohormetic, hormetic and 
cytostatic selective forces that drive the evolution of longevity regulation mechanisms at 
the ecosystemic level. In this hypothesis, the ability of a species of the organisms 
composing an ecosystem to undergo life-extending metabolic or physiological changes in 
response to hormetic or cytostatic chemical compounds released to the ecosystem by 
other species: 1) increases its chances of survival; 2) creates selective forces aimed at 
maintaining such ability; and 3) enables the evolution of longevity regulation 
mechanisms. 
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4 Using the experimental evolution of long-lived yeast species for testing our 
hypothesis of xenohormetic, hormetic and cytostatic forces driving the 
evolution of longevity regulation mechanisms within ecosystems  
 
4.1 Abstract 
In Chapter 3 of this Master’s thesis, we proposed that bile acids released into the 
environment by mammals may act as interspecies chemical signals providing longevity 
benefits to yeast and, perhaps, other species within an ecosystem. We hypothesized that, 
because bile acids are known to be mildly toxic compounds, they may create selective 
pressure for the evolution of yeast species that can respond to the bile acids-induced mild 
cellular damage by developing the most efficient stress protective mechanisms. It is 
likely that such mechanisms may provide effective protection of yeast against molecular 
and cellular damage accumulated with age. Thus, we proposed that yeast species that 
have been selected for the most effective mechanisms providing protection against bile 
acids may evolve the most effective anti-aging mechanisms that are sensitive to 
regulation by bile acids. We extended our hypothesis on longevity regulation by bile 
acids by suggesting a hypothesis of the xenohormetic, hormetic and cytostatic selective 
forces driving the evolution of longevity regulation mechanisms at the ecosystemic level. 
To verify our hypothesis empirically, we carried out the LCA-driven multistep selection 
of long-lived yeast species under laboratory conditions. We found that a lasting exposure 
of wild-type yeast to LCA results in selection of yeast species that live longer in the 
absence of this bile acid than their ancestor. Our data enabled to rank different 
concentrations of LCA with respect to the efficiency with which they cause the 
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appearance of long-lived yeast species. We revealed that, if used at the most efficient 
concentration of 5 μM, this bile acid induced life-extending mutations with the frequency 
of about 4 × 108/generation. At the concentration of 50 μM, LCA caused the appearance 
of long-lived species with the frequency of 1 × 108/generation, whereas a lasting 
exposure of yeast to 250 μM LCA did not result in selection of such species. Because the 
lowest used concentration of LCA resulted in the highest frequency of long-lived species 
appearance, we believe that it is unlikely that the life-extending mutations they carry are 
due to mutagenic action of this bile acid. 
 
We found that the evolved under laboratory conditions long-lived yeast species 3, 5 and 
12 were able to maintain their greatly extended CLS following numerous successive 
passages in medium without LCA under CR conditions. Our data imply that each of these 
long-lived yeast species also exhibited extended CLS when cultured in the absence of 
LCA under non-CR conditions (although to a lesser extent than that under CR 
conditions). Thus, consistent with its sought-after effect on longevity regulation 
pathways, our LCA-driven multistep selection process under laboratory conditions 
yielded long-lived yeast species whose greatly delayed chronological aging was caused 
by the selection of a mutant allele or alleles that activate so-called housekeeping 
longevity assurance pathways. These housekeeping longevity assurance pathways 
modulate longevity irrespective of the number of available calories and do not overlap 
with the adaptable longevity pathways that are under the stringent control of calorie 
availability [167].    
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4.2 Introduction 
We recently found that LCA greatly (and some other bile acids to a lesser degree) 
increases the chronological life span of yeast under caloric restriction (CR) conditions 
[167]. Our findings provided evidence that LCA extends longevity of chronologically 
aging yeast through two different mechanisms (Figure 4.1).  In one mechanism, this bile 
acid targets longevity pathways that control chronological aging irrespective of the 
number of calories available to yeast. Because these pathways modulate longevity 
regardless of calorie availability, we called them “constitutive” or “housekeeping” (see 
chapter 1 and 2) [167]. LCA modulates these housekeeping longevity assurance pathways 
by suppressing lipid-induced necrosis, attenuating mitochondrial fragmentation, altering 
oxidation-reduction processes in mitochondria, enhancing resistance to oxidative and 
thermal stresses, suppressing mitochondria-controlled apoptosis, and enhancing stability 
of nuclear and mitochondrial DNA ([167]; Figure 4.1C). The housekeeping longevity 
pathways do not overlap with the TOR (target of rapamycin) and cAMP/PKA 
(cAMP/protein kinase A) signaling pathways ([167]; Figure 4.1A), both of which are 
“adaptable” by nature because they are under the stringent control of calorie and/or 
nutrient availability ([4, 7, 10, 36, 221, 222]; Figure 4.1B). In the other mechanism, LCA 
targets the adaptable cAMP/PKA pathway by unmasking an anti-aging potential of PKA 
under non-CR conditions, perhaps by activating PKA-dependent phosphorylation of the 
cytosolic pool of the key nutrient-sensory protein kinase Rim15p (see chapters 1 and 2) 
[167]. The phosphorylation of Rim15p by PKA inactivates its protein kinase activity 
[58]. Hence, the LCA-driven inactivation of Rim15p may reduce the phosphorylation 
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Figure 4.1. Lithocholic acid (LCA) extends longevity of chronologically aging yeast 
through two different mechanisms. (A and B) Outline of pro- and anti-aging processes 
that are controlled by the TOR and/or cAMP/PKA signaling pathways and are modulated 
by LCA in yeast cells grown under non-CR (A) or CR (B) conditions. Activation arrows 
and inhibition bars denote pro-aging (displayed in green color) or anti-aging (displayed in 
red color) processes. Under both non-CR and CR conditions, LCA targets housekeeping 
longevity assurance processes listed in (C). Under non-CR conditions only, LCA also 
targets the adaptable cAMP/PKA pathway. By activating PKA-dependent 
phosphorylation of the cytosolic pool of the key nutrient-sensory protein kinase Rim15p, 
LCA causes the inactivation of Rim15p. The resulting reduction of the phosphorylation 
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status of several Rim15p target proteins in the cytosol lowers their pro-aging efficacy. 
Abbreviations: CR, caloric restriction; PM, plasma membrane. 
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Figure 4.2. Bile acids are beneficial to health and longevity in animals. (A) In mammals, 
bile acids (BA) function not only as trophic factors for the enteric epithelium and 
detergents for the emulsification and absorption of dietary lipids, but also as signaling 
molecules that regulate lipid, glucose and energy homeostasis and activate detoxification 
of xenobiotics. By improving overall health, BA may delay the onset of age-related 
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diseases and have beneficial effect on longevity. By activating transcription of numerous 
xenobiotic detoxification genes and thus promoting chemical hormesis, BA may extend 
their longevity by acting as endobiotic regulators of aging. (B) In worms, following their 
synthesis from cholesterol in the intestine, hypodermis, spermatheca and sensory 
neurons, bile acid-like dafachronic acids (DCA) are delivered to other tissues where they 
activate the DAF-12/DAF-16 signaling cascade, thereby orchestrating an anti-aging 
transcriptional program and increasing the life span of the entire organism. 
 
efficacy ([167]; Figure 4.1A). Although bile acids in mammals have been traditionally 
considered only as trophic factors for the enteric epithelium and detergents for the 
emulsification and absorption of dietary lipids [168 - 170], they are now also recognized 
for their essential role as signaling molecules regulating lipid, glucose and energy 
homeostasis and activating  detoxification of xenobiotics ([168 - 173]; Figure 4.2A).  
Many of the numerous health-improving metabolic effects caused by bile acids and their 
demonstrated ability to protect mammals from xenobiotic toxins ([169 - 173]; Figure 
4.2A) suggest that, by improving overall health, these amphipathic molecules may delay 
the onset of age-related diseases and have beneficial effect on longevity. Furthermore, 
because  of  the  elevated  levels of several bile acids in the long-lived Ghrhrlit/lit mice and 
due to the ability of cholic acid administered to food of wild-type mice to activate 
transcription of numerous xenobiotic detoxification genes, it has been proposed that, by 
promoting chemical hormesis in mammals, these mildly toxic molecules with detergent-
like properties may extend their longevity by acting as endobiotic regulators of aging 
[174 - 177]. Moreover, bile acid-like dafachronic acids (including 3-keto-LCA) in worms 
function as endocrine regulators of aging by activating an anti-aging transcriptional 
program governed by the DAF-12/DAF-16 signaling cascade ([157, 224, 225]; Figure 
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4.2B). Altogether, these findings support the notion that bile acids are beneficial to health 
and longevity in animals because of their ability to operate as potent signaling molecules 
that modulate a compendium health- and longevity-related processes. Noteworthy, by 
modulating many of these processes also in yeast, LCA extends their longevity [167]. It 
is likely therefore that the life-extending capacity of LCA and other bile acids as well as, 
perhaps, the mechanisms underlying their anti-aging action are conserved across animal 
species and other phyla.  
 
4.3 Materials and Methods 
Strains and media 
The wild type strain Saccharomyces cerevisiae BY4742 (MATα, his3Δ leu2Δ0 lys2Δ 
ura3Δ0) was cultured in liquid YP medium (1% yeast extract, 2% peptone) contained 
0.2% glucose as a carbon source, with or without LCA, as detailed in the “Results” 
section. Cell cultures were incubated at 30°C with rotational shaking at 200 rpm in 
Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1. For a spot assay of 
cell viability, serial 10-fold dilutions of cell cultures were spotted onto plates with solid 
YP medium (1% yeast extract, 2% peptone) containing 2% glucose.  
 
4.4 Results 
4.4.1 The LCA-driven multistep selection of long-lived yeast species under 
laboratory conditions 
To empirically verify our hypothesis of the xenohormetic, hormetic and cytostatic 
selective forces driving the evolution of longevity regulation mechanisms at the 
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ecosystemic level, we carried out a 3-step selection of long-lived yeast species by a 
lasting exposure to LCA under laboratory conditions. For the first step of such selection, 
yeast cells from an overnight culture were inoculated into a fresh YP medium (with or 
without LCA) containing 0.2% glucose to the initial cell titre of 1 × 105 cells/ml (Figure 
4.3). After one week of the incubation in this medium and following approximately 45 
cell generations, yeast entered into a non-proliferative state by reaching stationary (ST) 
growth phase at the cell titre of 2 × 108 cells/ml (Figure 4.5). Following their entry into a 
non-proliferative state, yeast cells were cultured for additional 5 weeks. By the end of this 
cultivation, only ~ 0.02% of cells in the medium without LCA remained viable. In the 
cell cultures that were supplemented with LCA, ~ 1% of cells remained viable – due to 
the ability of LCA to increase the chronological life span (CLS) of non-dividing 
(senescent) yeast cells. Thus, the enrichment factor for long-lived mutants by the end of 
each selection step was 102 (Figure 4.5). Five cultures were used to carry out the 
selection of long-lived yeast species: the first culture lacked LCA; the second culture 
contained 5 μM LCA added at the moment of cell inoculation; the third culture contained 
50 μM LCA added at the moment of cell inoculation; the fourth culture contained 250 
μM LCA added at the moment of cell inoculation; and the fifth culture was supplemented 
with 10 doses of 5 μM LCA each by adding this bile acid every 3 or 4 days (Figure 4.6). 
At the end of the first selection step, aliquots of each of the five cultures were plated onto 
plates with solid YP medium containing 2% glucose. After 2 days, each of the 10 
randomly chosen colonies was inoculated into a liquid medium without LCA to carry out 
a viability testing step (Figure 4.3). Every week, an aliquot of each culture was used for a 
spot  assay of cell viability to identify long-lived mutants (if any) induced due to a lasting 
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exposure of yeast to LCA during the selection step (Figure 4.3). If such mutants were 
detected, an aliquot of their culture in medium lacking LCA was frozen at -80oC. 
  
STEP 1: 1 week (~45 
generations) + 5 
weeks (ST phase)
LA
Initial cell titre: 1×105/ml 
Cell viability: 100% (both)
Cell titre: 2×108/ml 
Cell viability: 0.02% (- LA) 
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STEP 2 
YEPD plates Inoculate each of the 10 randomly chosen 
colonies in a flask with 
medium without LA













Figure 4.3. A 3-step process of the LCA-driven experimental evolution of longevity 
regulation mechanisms by conducting selection of long-lived yeast species through a 
lasting exposure to LCA. See text for details. 
 
To conduct the second selection step, an aliquot of the culture recovered at the end of the 
first step of selection was diluted 100 folds in a fresh YP medium containing 0.2% 
glucose,  with  or  without  LCA;  if added to a culture for the second selection step, LCA 
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Initial cell titre: 1×105/ml 
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Cell titre: 2×108/ml 
Cell viability: 0.02% (- LA) 












or + LA) & 
then repeat 
STEP 2 
YEPD plates Inoculate each of the 10 randomly chosen 
colonies in a flask with 
medium without LA






Spot assays for 
identifying a long-
lived mutant
The number of cell 
generations in each of 
the selection steps 
prior to entry into a 
non-proliferative state 
(i.e., stationary phase 
[ST] of senescence):
(2 x 108 cells/ml) : 
(105 cells/ml) = 2,000 
~ 45 generations
Figure 4.4. A 3-step process of the LCA-driven experimental evolution of longevity 
regulation mechanisms by conducting selection of long-lived yeast species through a 
lasting exposure to LCA. The number of cell generations in each of the selection steps 
prior to entry into a non-proliferative state is calculated. See text for details. 
 
was present at the same final concentration as that in the medium used for the first step of 
selection (Figure 4.3). From that point, the second selection step was carried out exactly 
as the first one and was followed by a spot-assay viability step described above (Figure 
4.3). The second selection step was followed by the third selection step and then by a 
spot-assay viability step, both conducted as described previously (Figure 4.3).             
 70 
STEP 1: 1 week (~45 
generations) + 5 
weeks (ST phase)
LA
Initial cell titre: 1×105/ml 
Cell viability: 100% (both)
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the end of each of the 5-
weeks selection steps 
(in LA-treated samples):
100% viable cells 
(start) : 1% viable long-
lived cells (end) = 102
 
Figure 4.5. A 3-step process of the LCA-driven experimental evolution of longevity 
regulation mechanisms by conducting selection of long-lived yeast species through a 
lasting exposure to LCA. The enrichment factor for long-lived mutants by the end of each 
of the selection steps is calculated. See text for details. 
 
The 3-step selection of long-lived yeast species depicted in Figures 4.3 to 4.6 was 
expected to result in the increased fraction of long-lived mutants in a population of yeast 
exposed to LCA (Figure 4.7). Moreover, the fraction of such long-lived mutants in a 
population was anticipated to progressively increase at each of the consecutive selection 
steps (Figure 4.7 and Table 4.1).   
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used during each of the 
selection steps:
Sample 1: no LA
Sample 2: 5 μM LA
Sample 3: 50 μM LA
Sample 4: 250 μM LA
Sample 5: 10 doses x 5 
μM LA added every 3-4 
days
 
Figure 4.6. A 3-step process of the LCA-driven experimental evolution of longevity 
regulation mechanisms by conducting selection of long-lived yeast species through a 
lasting exposure to LCA. Concentrations of LCA used during each of the selection steps 
are shown. See text for details. 
 
By carrying out this 3-step selection of long-lived yeast species under laboratory 
conditions, we found no such mutants at the end of the first selection step, 4 mutants at 
the end of the second selection step, and 16 mutants at the end of the third selection step 
(Figures 4.8, 4.90 and 4.10, respectively). We therefore concluded that a long-term 
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Figure 4.7. The fraction of long-lived mutants in a population of yeast is increased by the 
end of each of the 3 steps of the LCA-driven experimental evolution of longevity 
regulation mechanisms. 
 
of yeast species that live longer in the absence of LCA than their ancestor. Our findings 
revealed the following order of different LCA concentrations ranked by the efficiency 
with which they cause the appearance of long-lived species (frequencies of such 
appearance are shown): 5 μM LCA (~4 × 10-8/generation) > 10 doses x 5 μM LCA (~3 × 
10-8/generation) > 50 μM LCA (~1 × 10-8/generation) > 250 μM LCA (no long-lived 
species found). It should be emphasized that, because the lowest used concentration of 
LCA resulted in the highest frequency of long-lived species appearance, it is unlikely that 






Table 4.1. The fraction of long-lived mutants in a population of yeast is increased by the 
end of each of the 3 steps of the LCA-driven experimental evolution of longevity 
regulation mechanisms. 
4-5 out of 
1,000
STEP 1: (10-6 × 45 generations) × 102 = 4.5 × 10-3 
10210-6/ 
generation
4-5 out of 
10
STEP 2: [(4.5 × 10-3) + (10-6 × 45 gen.)] × 102 ~ 4.5 × 10-1
ALLSTEP 3: [(4.5 × 10-1) + (10-6 × 30 gen.)] × 102 ~ 4.5 × 101
4-5 out of 
10,000
STEP 1: (10-7 × 45 generations) × 102 = 4.5 × 10-4 
10210-7/ 
generation
4-5 out of 
100
STEP 2: [(4.5 × 10-4) + (10-7 × 45 gen.)] × 102 ~ 4.5 × 10-2
ALLSTEP 3: [(4.5 × 10-2) + (10-7 × 45 gen.)] × 102 ~ 4.5 × 100
4-5 out of 
10
STEP 3: [(4.5 × 10-3) + (10-8 × 45 gen.)] × 102 ~ 4.5 × 10-1
4-5 out of 
1,000
STEP 2: [(4.5 × 10-5) + (10-8 × 45 gen.)] × 102 ~ 4.5 × 10-3
4-5 out of 
100,000




The fraction of long-lived mutants & their number in a population of 













4.4.2 Three long-lived yeast species evolved under laboratory conditions were able 
to maintain their greatly extended life spans following numerous passages in 
medium without LCA  
The 3 steps of experimental evolution of long-lived yeast species by a prolonged 
exposure of wild-type yeast to LCA resulted in selection of 20 species that in a spot-assay 
lived longer than their ancestor in medium lacking LCA (see Figures 4.8 – 4.10). An 
aliquot of the culture of each of these long-lived yeast species was frozen at -80oC 
immediately  after  being  recovered  during  the second or third selection step. To test the 
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Figure 4.8. A spot-assay of cell survival for the 1st step of the LCA-driven experimental  
evolution of longevity regulation mechanisms.  
 
 
Figure 4.9. A spot-assay of cell survival for the 2nd step of the LCA-driven experimental  




Figure 4.10. A spot-assay of cell survival for the 3rd step of the LCA-driven  
experimental evolution of longevity regulation mechanisms. 
 
ability of these species to maintain their greatly extended life spans following the 1st 
passage in medium without LCA, each aliquot was thawed and then inoculated into liquid 
YP medium lacking this bile acid and containing 0.2% glucose. Our comparative analysis 
of the chronological life spans (CLS) of wild-type (WT) strain and all of these selected 
long-lived yeast species revealed that species 3, 5 and 12 maintained their ability to live 
much longer than WT following the 1st passage (Figure 4.11).     
 
The selected long-lived yeast species 3, 5 and 12 underwent four more passages (each 
carried out as described for the 1st passage) in liquid medium without LCA and then 
tested again for their ability to maintain greatly extended life spans, now following five 
successive passages in medium without LCA. As we found, each of these three long-
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lived yeast species evolved under laboratory conditions maintained its greatly extended 




Figure 4.11. The selected long-lived yeast species 3, 5 and 12 maintain their ability to 
live much longer than WT following the 1st passage in medium lacking LCA. Survival of 
chronologically aging WT and of the yeast species 3, 5 and 12 cultured under CR 
conditions in liquid YP medium initially containing 0.2% glucose without LCA. 
 
4.4.3  The selected under CR long-lived yeast species 3, 5 and 12 exhibit extended 
CLS when cultured in medium without LCA under non-CR conditions, although to 
a lesser extent than that under CR conditions 
When  the  selected  long-lived  yeast  species  3, 5 and 12 that underwent five successive   
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passages in medium without LCA under CR were cultured under non-CR conditions on 
2% glucose in the absence of this bile acid, each of them exhibited extended CLS as 
compared to WT (Figure 4.13). For each of these three species, the efficacy of CLS 
extension under CR conditions exceeded that under non-CR conditions (Figure 4.13). 
    
 
 
Figure 4.12. The selected long-lived yeast species 3, 5 and 12 maintain their ability to 
live much longer than WT following five successive passages in medium lacking LCA. 
Survival of chronologically aging WT and of the yeast species 3, 5 and 12 cultured under 




Figure 4.13. Following five successive passages in medium lacking LCA, the selected 
under CR long-lived yeast species 3, 5 and 12 exhibit extended CLS when cultured in 
medium without LCA under non-CR conditions - although to a lesser extent than that 
under CR conditions. Survival of chronologically aging WT and of the yeast species 3, 5 
and 12 cultured under CR conditions in liquid YP medium initially containing 0.2% 
glucose without LCA. 
 
4.5 Discussion 
To verify empirically our hypothesis of the xenohormetic, hormetic and cytostatic 
selective forces driving the evolution of longevity regulation mechanisms at the 
ecosystemic level, we carried out the LCA-driven multistep selection of long-lived yeast 
species under laboratory conditions. We found that a lasting exposure of WT yeast to 
LCA results in selection of yeast species that live significantly longer in the absence of 
this bile acid than their ancestor. Our data enabled to rank different concentrations of 
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LCA with respect to the efficiency with which they cause the appearance of long-lived 
yeast species. Because the lowest used concentration of LCA resulted in the highest 
frequency of long-lived species appearance, it seems unlikely that the life-extending 
mutations they carry are due to mutagenic action of this bile acid. The evolved under 
laboratory conditions long-lived yeast species 3, 5 and 12 were able to maintain their 
greatly extended CLS following numerous successive passages in medium without LCA 
under CR conditions. Importantly, each of these long-lived yeast species also exhibited 
extended CLS when cultured in the absence of LCA under non-CR conditions (although 
to a lesser extent than that under CR conditions). Thus, consistent with its sought-after 
effect on longevity regulation pathways, our LCA-driven multistep selection process 
under laboratory conditions yielded long-lived yeast species whose greatly delayed 
chronological aging was caused by the selection of a mutant allele or alleles that activate 
so-called housekeeping longevity assurance pathways. These housekeeping longevity 
assurance pathways modulate longevity irrespective of the number of available calories 
and do not overlap with the adaptable longevity pathways that are under the stringent 
control of calorie availability [167].          
 
4.6 Conclusions 
In experiments described in this Chapter, we verified empirically our hypothesis that the 
evolution of longevity regulation mechanisms within an ecosystem can be driven by the 
xenohormetic, hormetic and cytostatic selective forces created by a lasting exposure of an 
organism to an anti-aging natural compound released by other organisms composing this 
ecosystem. Indeed, a long-term exposure of wild-type yeast to LCA (a bile acid that 
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under field-like conditions is synthesized and released into the environment by mammals) 
results in selection of yeast species that live longer in the absence of this bile acid than 
their ancestor. To test the validity of other aspects of our hypothesis on the ecosystemic 
evolution of longevity regulation mechanisms, future studies need to address the 
following most critical questions: 1) what genes are affected by mutations responsible for 
the extended longevity of selected long-lived yeast species? 2) how these mutations 
influence a compendium of the housekeeping longevity-related processes modulated by 
LCA in chronologically aging yeast ([167]; Figure 4.1)?; 3) 3) will these mutations affect 
the growth rate of yeast in media with or without LCA? 4) will selected long-lived yeast 
species be able to maintain their ability to live longer than wild-type yeast if they undergo 
several successive passages in medium without LCA? - and, thus, is there selective 
pressure aimed at maintaining of an “optimal” rather than a “maximal” chronological life 
span of yeast (due to, e.g., a proposed selective advantage of the envisioned “altruistic” 
program [226 - 231] of chronological aging in yeast)? and 5) if mixed with an equal 
number of wild-type yeast cells, will selected long-lived yeast species out-grow and/or 
out-live them in medium without LCA or the opposite will happen (due to selective 
pressure on yeast aimed at maintaining of the so-called “altruistic” program [226 - 231] 
of their chronological aging)? 
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5 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 affect a compendium of the 
housekeeping longevity-related processes modulated by LCA in 
chronologically aging yeast  
 
5.1 Abstract 
In experiments described in Chapter 4 of this Master’s thesis, we verified empirically our 
hypothesis that the evolution of longevity regulation mechanisms within an ecosystem 
can be driven by the xenohormetic, hormetic and cytostatic selective forces created by a 
lasting exposure of an organism to an anti-aging natural compound released by other 
organisms composing this ecosystem. Specifically, we found that a long-term exposure of 
wild-type yeast to LCA (a bile acid that under field-like conditions is synthesized and 
released into the environment by mammals) results in selection of yeast species that live 
longer in the absence of this bile acid than their ancestor.  
 
To test the validity of other aspects of our hypothesis on the ecosystemic evolution of 
longevity regulation mechanisms, we assessed how a mutant allele or alleles selected 
during the LCA-driven multistep selection process of long-lived yeast species 3, 5 and 12 
influence a compendium of the housekeeping longevity-related processes that, as we 
revealed [167], are modulated by LCA in chronologically aging yeast. We found that in 
the absence of LCA this allele or alleles alter the age-dependent dynamics of 
mitochondrial respiration under both CR and non-CR conditions. This finding further 
confirms our conclusion (see Chapter 4 of this Master’s thesis) that, consistent with its 
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sought-after effect on longevity regulation pathways, our LCA-driven multistep selection 
process under laboratory conditions yielded long-lived yeast species whose greatly 
delayed chronological aging was caused by the selection of a mutant allele or alleles that 
activate so-called housekeeping longevity assurance pathways. As we previously 
demonstrated, these housekeeping longevity assurance pathways modulate longevity 
irrespective of the number of available calories and do not overlap with the adaptable 
longevity pathways that are under the stringent control of calorie availability [167]. 
 
We also revealed that under CR conditions in the absence of LCA a mutant allele or 
alleles selected during the LCA-driven multistep selection process of long-lived yeast 
species: 1) enhance the resistance of yeast to chronic oxidative, thermal and osmotic 
stresses; 2) suppress mitochondria-controlled apoptotic cell death triggered by 
exogenously added hydrogen peroxide; and 3) attenuate lipid-induced necrotic cell death 
induced by exogenously added palmitoleic acid.  
 
As we found, the addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions 1) further extends their chronological life spans (CLS), although to a lesser 
degree than that of WT; 2) causes further changes in the age-dependent dynamics of 
mitochondrial respiration, although not as dramatic as those seen in WT; 3) further 
enhances the resistance of yeast to chronic oxidative, thermal and osmotic stresses, 
although to a lesser extent than those observed in WT; 4) further suppresses 
mitochondria-controlled apoptotic cell death triggered by exogenously added hydrogen 
peroxide, although to a lesser degree than those seen in WT; and 5) further attenuates 
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lipid-induced necrotic cell death induced by exogenously added palmitoleic acid, 
although to a lesser extent than those observed in WT. We therefore concluded that, 
although a mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 greatly impact a compendium of the LCA-
sensing housekeeping longevity assurance processes, this allele or alleles do not activate 
such processes sufficiently enough to attain the maximal CLS achievable under life-
extending CR conditions in the presence of LCA.  
 
Altogether, these findings further confirm the validity of our hypothesis in which the 
evolution of longevity regulation mechanisms within an ecosystem can be driven by the 
xenohormetic, hormetic and cytostatic selective forces created by a lasting exposure of an 




We recently found that under field-like CR conditions LCA extends longevity of 
chronologically aging yeast cultured under laboratory conditions by modulating the 
housekeeping longevity assurance pathways, and thereby 1) altering the age-dependent 
dynamics of mitochondrial respiration and of some other oxidation-reduction processes in 
mitochondria; 2) enhancing resistance to chronic oxidative, thermal and osmotic stresses; 
3) suppressing mitochondria-controlled apoptotic cell death; and 4) attenuating lipid-
induced necrotic cell death [167]. By conducting the LCA-driven multistep selection of 
long-lived yeast under laboratory conditions (which is described in Chapter 4 of this 
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Master’s thesis), we selected the new yeast species 3, 5 and 12 that live significantly 
longer in the absence of LCA than their ancestor. Because the evolution of these long-
lived yeast species under laboratory conditions was driven by LCA, one could assume 
that a mutant allele or alleles selected during such evolution affect the same set of the 
housekeeping longevity-related processes that are modulated by LCA in chronologically 
aging yeast. In a series of experiments described in this Chapter of the thesis, we tested 
the validity of our assumption.    
 
5.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα, his3Δ leu2Δ0 lys2Δ 
ura3Δ0) and long-lived mutant species 3, 5 and 12 derived from this strain were cultured 
in liquid YP medium (1% yeast extract, 2% peptone) contained 0.2% or 2% glucose as a 
carbon source, with or without LCA, as detailed in the “Results” section. Cell cultures 
were incubated at 30°C with rotational shaking at 200 rpm in Erlenmeyer flasks at a 
“flask volume/medium volume” ratio of 5:1.  
 
A plating assay for the analysis of chronological life span (CLS) 
Cells were grown in YP medium initially containing 0.2% or 2% glucose as carbon 
source at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a flask 
volume/medium volume ratio of 5:1. A sample of cells was removed from each culture at 
various time points. A fraction of the cell sample was diluted in order to determine the 
total number of cells per ml of culture using a hemacytometer. 10 Pl of serial dilutions 
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(1:10 to 1:103) of cells were applied to the hemacytometer, where each large square is 
calibrated to hold 0.1 Pl. The number of cells in 4 large squares was then counted and an 
average was taken in order to ensure greater accuracy. The concentration of cells was 
calculated as follows: number of cells per large square x dilution factor × 10 × 1,000 = 
total number of cells per ml of culture. A second fraction of the cell sample was diluted 
and serial dilutions (1:102 to 1:105) of cells were plated onto YEPD (2% Glucose) plates 
in triplicate in order to count the number of viable cells per ml of each culture. 100 Pl of 
diluted culture was plated onto each plate. After 48-h incubation at 30oC, the number of 
colonies per plate was counted. The number of colony forming units (CFU) equals to the 
number of viable cells in a sample. Therefore, the number of viable cells was calculated 
as follows: number of colonies × dilution factor × 10 = number of viable cells per ml. For 
each culture assayed, % viability of the cells was calculated as follows: number of viable 
cells per ml / total number of cells per ml × 100%. The % viability of cells in mid-
logarithmic phase was set at 100% viability for that particular culture. 
 
Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
measured continuously in a 2-ml stirred chamber using a custom-designed biological 
oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 1 ml of YP medium supplemented with 0.2% glucose was 
added to the electrode for approximately 5 minutes to obtain a baseline. Cultured cells of 
a known titre were spun down at 3,000 × g for 5 minutes. The resulting pellet was 
resuspended in YP medium supplemented with 0.2% glucose and then added to the 
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electrode with the medium that was used to obtain a baseline. The resulting slope was 
used to calculate the rate of oxygen consumption in O2% × min-1 × 109 cells. 
 
Plating assays for the analysis of resistance to various chronic stresses 
For the analysis of oxidative stress resistance, serial dilutions (1:10 to 1:105) of wild-type 
and mutant cells removed from various phases of growth YP medium initially containing 
0.2% glucose were spotted onto two sets of plates. One set of plates contained YEPD 
(2% Glucose) medium alone, whereas the other set contained YEPD (2% Glucose) 
medium supplemented with 5 mM hydrogen peroxide. Pictures were taken after 3-day 
incubation at 30oC. 
 
For the analysis of heat-shock resistance, serial dilutions (1:10 to 1:105) of wild-type and 
mutant cells removed from various phases of growth YP medium initially containing 
0.2% glucose were spotted onto two sets of YEPD (2% Glucose) plates. One set of plates 
was incubated at 30oC. The other set of plates was initially incubated at 55oC for 30 min, 
and was then transferred to 30oC. Pictures were taken after 3-day incubation at 30oC. 
 
For the analysis of osmotic (salt stress) resistance, serial dilutions (1:10 to 1:105) of wild-
type and mutant cells removed from various phases of growth YP medium initially 
containing 0.2% glucose were spotted onto two sets of plates. One set of plates contained 
YEPD (2% Glucose) medium alone, whereas the other set contained YEPD (2% 
Glucose) medium supplemented with 1M NaCl. Pictures were taken after 3-day 
incubation at 30oC. 
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5.4 Results 
5.4.1 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 alter the age-dependent 
dynamics of mitochondrial respiration under CR and non-CR conditions 
We found that in wild-type (WT) yeast grown under CR conditions on 0.2% glucose 
without LCA, the rate of oxygen consumption by mitochondria was 1) greatly amplified 
when yeast entered diauxic (D) growth phase that begins on day 2 of culturing; and 2) 
sharply declined during the subsequent post-diauxic (PD; occurs between days 3 and 7 of 
culturing) phase of growth; and 3) gradually reduced during stationary (ST; begins after 
day 7 of culturing) growth phase that follows PD phase (Figure 5.1). In contrast, in long-
lived yeast species 3, 5 and 12 grown under CR conditions on 0.2% glucose without 
LCA, the rate of oxygen consumption by mitochondria 1) was amplified to a significantly 
lesser extent during D phase than it was in WT yeast cultured on 0.2% glucose; 2) did not 
declined as sharply during the subsequent PD phase of growth as it was in WT yeast 
cultured under these conditions; and 3) was elevated again for a long period of time 
during ST phase (to the level similar to that seen in these yeast species during PD phase) 
and began to decline slowly only deep into ST phase – unlike the situation seen in WT 
yeast cultured under these conditions (Figure 5.1). 
 
A similar effect of a mutant allele or alleles selected during the LCA-driven multistep 
selection process of long-lived yeast species 3, 5 and 12 on the age-dependent dynamics 
of mitochondrial respiration was observed in yeast grown under non-CR conditions on 















Figure 5.1. A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 alter the age-dependent dynamics of 
mitochondrial respiration under CR conditions. The dynamics of age-dependent changes 
in the rate of oxygen consumption by cells of WT strain and yeast species 3, 5 and 12. 
Cells were cultured in YP medium without LCA initially containing 0.2% glucose. 
 
consumption by cells of WT strain and yeast species 3, 5 and 12 were lower during D, 
PD and ST phases than those seen in their counterparts cultured under CR conditions; and 
2) the differences between cells of WT and yeast species 3, 5 and 12 in amplitudes of the 
oxygen consumption amplification during D phase, its decline during the subsequent PD 
phase and its strain-characteristic changes during ST phase were less pronounced than 
those observed in their counterparts cultured under CR conditions (Figure 5.2). 
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Figure 5.2. A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 alter the age-dependent dynamics of 
mitochondrial respiration under non-CR conditions. The dynamics of age-dependent 
changes in the rate of oxygen consumption by cells of WT strain and yeast species 3, 5 
and 12. Cells were cultured in YP medium without LCA initially containing 2% glucose. 
 
5.4.2 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 enhance the resistance of yeast 
to chronic oxidative, thermal and osmotic stresses under CR conditions 
We recently demonstrated that under CR conditions LCA extends longevity of 
chronologically aging yeast by activating a set of housekeeping longevity assurance 
processes leading, in part, to the enhanced resistance of yeast to chronic oxidative, 
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thermal and osmotic stresses [167]. Because the evolution of long-lived yeast species 3, 5 
and 12 under laboratory conditions was driven by LCA, one could assume that a mutant 
allele or alleles selected during such evolution further activate the same set of the 
housekeeping assurance processes that are activated by LCA in chronologically aging 
WT yeast. In fact, we found that this mutant allele or alleles enhance the resistance of 
yeast cultured under CR conditions without LCA to chronic oxidative, thermal and 
osmotic stresses (Figure 5.3). 
 
5.4.3 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 suppress mitochondria-
controlled apoptotic cell death triggered by exogenously added hydrogen 
peroxide under CR conditions 
As we recently showed, under CR conditions LCA extends longevity of chronologically 
aging yeast by activating a set of housekeeping longevity assurance processes leading, in 
part, to the reduced susceptibility of yeast to cell death triggered by a short-term exposure 
to exogenous hydrogen peroxide and caused by mitochondria-controlled apoptosis [167]. 
Because the evolution of long-lived yeast species 3, 5 and 12 under laboratory conditions 
was driven by LCA, it is conceivable that a mutant allele or alleles selected during such 
evolution further activate the same set of the housekeeping assurance processes that are 
activated by LCA in chronologically aging WT yeast. In fact, we found that in yeast 
cultured under CR conditions without LCA this mutant allele or alleles suppress 
mitochondria-controlled apoptotic cell death triggered by exogenously added hydrogen 































Figure 5.3. A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 enhance the resistance of yeast cultured 
under CR conditions without LCA to chronic oxidative, thermal and osmotic stresses. 
Yeast cells were grown in YP medium without LCA initially containing 0.2% glucose. 
Cell aliquots were recovered from various growth phases. The resistance of yeast to 
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Materials and Methods section. Abbreviations: D, diauxic growth phase; L, logarithmic 




Figure 5.4. A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 suppress mitochondria-controlled 
apoptotic cell death triggered by exogenously added hydrogen peroxide in yeast cultured 
under CR conditions without LCA. Yeast cells were pre-grown in YP medium without 
LCA initially containing 0.2% glucose. Cell aliquots were recovered from various growth 
phases and then treated for 2 h with 2.5 mM hydrogen peroxide to induce mitochondria-
controlled apoptosis. Abbreviations: D, diauxic growth phase; L, logarithmic growth 





Figure 5.5. In yeast cultured under CR conditions without LCA, a mutant allele or alleles 
selected during the LCA-driven multistep selection process of long-lived yeast species 3, 
5 and 12 attenuate lipid-induced necrotic cell death induced by exogenously added 
palmitoleic acid. Yeast cells were pre-grown in YP medium without LCA initially 
containing 0.2% glucose. Cell aliquots were recovered from various growth phases and 
then exposed for 2 h to 0.2 mM palmitoleic acid to induce a necrotic mode of cell death. 
Abbreviations: D, diauxic growth phase; L, logarithmic growth phase; PD, post-diauxic 
growth phase; ST, stationary growth phase. 
 
5.4.4 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 attenuate lipid-induced 
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necrotic cell death induced by exogenously added palmitoleic acid under CR 
conditions 
A set of housekeeping longevity assurance processes whose activation by LCA under CR 
conditions partially underlies the anti-aging effect of LCA includes an attenuation of 
lipid-induced necrotic cell death induced by exogenously added palmitoleic acid [167]. 
One could expect that due to the fact that LCA has been a driving force for the evolution 
of long-lived yeast species 3, 5 and 12 under laboratory conditions, a mutant allele or 
alleles selected during such evolution would further reduce susceptibility of yeast to this 
mode of cell death. Indeed, in yeast cultured under CR conditions without LCA this 
mutant allele or alleles attenuated lipid-induced necrotic cell death triggered by a short-
term exposure to exogenous palmitoleic acid (Figure 5.5). 
 
5.4.5 A mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 do not activate the LCA-
sensing housekeeping longevity assurance processes sufficiently enough to 
attain the maximal CLS achievable under CR conditions in the presence of 
LCA  
We found that the addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions further extends their CLS, although to a lesser degree than that of WT 
(Figure 5.6). This finding implies that, although a mutant allele or alleles selected during 
the   LCA-driven  multistep  selection  process  of  these  yeast  species  greatly  impact  a 
compendium of the LCA-sensing housekeeping longevity assurance processes (see 
Figures 5.1 to 5.5), this allele or alleles do not activate such processes sufficiently enough   
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Figure 5.6. The addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions further extends their CLS, although to a lesser degree than that of WT. 
Survival of chronologically aging WT and of the yeast species 3, 5 and 12 cultured under 




Figure 5.7. The addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions causes further changes in the age-dependent dynamics of mitochondrial 
respiration, although not as dramatic as those seen in WT. The dynamics of age-
dependent changes in the rate of oxygen consumption by cells of WT strain and yeast 
species 3, 5 and 12. Cells were under CR conditions in liquid YP medium initially 
containing 0.2% glucose without (A) or with (B) LCA. 
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Figure 5.8. The addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions further enhances the resistance of yeast to chronic oxidative, thermal and 
osmotic stresses, although to a lesser extent than those observed in WT. Yeast cells were 
grown in YP medium initially containing 0.2% glucose, with or without LCA. Cell 
aliquots were recovered from various growth phases. The resistance of yeast to chronic 
oxidative, thermal and osmotic stresses was monitored as described in the Materials and 
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Methods section. Abbreviations: D, diauxic growth phase; L, logarithmic growth phase; 
PD, post-diauxic growth phase; ST, stationary growth phase. 
 
 
Figure 5.9. The addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions further suppresses mitochondria-controlled apoptotic cell death triggered 
by exogenously added hydrogen peroxide, although to a lesser degree than those seen in 
WT. Yeast cells were pre-grown under CR conditions in liquid YP medium initially 
containing 0.2% glucose without (A) or with (B) LCA. Cell aliquots were recovered from 
various growth phases and then treated for 2 h with 2.5 mM hydrogen peroxide to induce 
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mitochondria-controlled apoptosis. Abbreviations: D, diauxic growth phase; L, 
logarithmic growth phase; PD, post-diauxic growth phase; ST, stationary growth phase. 
 
 
Figure 5.10. The addition of LCA to long-lived yeast species 3, 5 and 12 cultured under 
CR conditions further attenuates lipid-induced necrotic cell death induced by 
exogenously added palmitoleic acid, although to a lesser extent than those observed in 
WT. Yeast cells were pre-grown under CR conditions in liquid YP medium initially 
containing 0.2% glucose without (A) or with (B) LCA. Cell aliquots were recovered from 
various growth phases and then exposed for 2 h to 0.2 mM palmitoleic acid to induce a 
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necrotic mode of cell death. Abbreviations: D, diauxic growth phase; L, logarithmic 
growth phase; PD, post-diauxic growth phase; ST, stationary growth phase. 
 
to attain the maximal CLS achievable under life-extending CR conditions in the presence 
of LCA. In support of this notion, we revealed that the addition of LCA to long-lived 
yeast species 3, 5 and 12 cultured under CR conditions 1) causes further changes in the 
age-dependent dynamics of mitochondrial respiration, although not as dramatic as those 
seen in WT (Figure 5.7); 2) further enhances the resistance of yeast to chronic oxidative, 
thermal and osmotic stresses, although to a lesser extent than those observed in WT 
(Figure 5.8); 3) further suppresses mitochondria-controlled apoptotic cell death triggered 
by exogenously added hydrogen peroxide, although to a lesser degree than those seen in 
WT (Figure 5.9); and 4) further attenuates lipid-induced necrotic cell death induced by 
exogenously added palmitoleic acid, although to a lesser extent than those observed in 
WT (Figure 5.10).  
 
5.5 Conclusions 
A described in this Chapter observation that a mutant allele or alleles selected during the 
LCA-driven multistep selection process of long-lived yeast species 3, 5 and 12 alter the 
age-dependent dynamics of mitochondrial respiration under both CR and non-CR 
conditions further confirms our conclusion (see Chapter 4 of this Master’s thesis) that, 
consistent with its sought-after effect on longevity regulation pathways, our LCA-driven 
multistep selection process under laboratory conditions yielded long-lived yeast species 
whose greatly delayed chronological aging was caused by the selection of a mutant allele 
or alleles that activate so-called housekeeping longevity assurance pathways.    
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Findings described in this Chapter also imply that under CR conditions in the absence of 
LCA a mutant allele or alleles selected during the LCA-driven multistep selection process 
of long-lived yeast species: 1) enhance the resistance of yeast to chronic oxidative, 
thermal and osmotic stresses; 2) suppress mitochondria-controlled apoptotic cell death 
triggered by exogenously added hydrogen peroxide; and 3) attenuate lipid-induced 
necrotic cell death induced by exogenously added palmitoleic acid. As we previously 
demonstrated, all these processes are governed by the housekeeping longevity assurance 
pathways that modulate longevity irrespective of the number of available calories [167]. 
 
Moreover, the experiments described in this Chapter revealed that the addition of LCA to 
long-lived yeast species 3, 5 and 12 cultured under CR conditions 1) further extends their 
CLS, although to a lesser degree than that of WT; 2) causes further changes in the age-
dependent dynamics of mitochondrial respiration, although not as dramatic as those seen 
in WT; 3) further enhances the resistance of yeast to chronic oxidative, thermal and 
osmotic stresses, although to a lesser extent than those observed in WT; 4) further 
suppresses mitochondria-controlled apoptotic cell death triggered by exogenously added 
hydrogen peroxide, although to a lesser degree than those seen in WT; and 5) further 
attenuates lipid-induced necrotic cell death induced by exogenously added palmitoleic 
acid, although to a lesser extent than those observed in WT. Altogether, these findings 
imply that, although a mutant allele or alleles selected during the LCA-driven multistep 
selection process of long-lived yeast species greatly impact a compendium of the LCA-
sensing housekeeping longevity assurance processes, this allele or alleles do not activate 
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such processes sufficiently enough to attain the maximal CLS achievable under life-
extending CR conditions in the presence of LCA.  
 
In sum, findings presented on this Chapter further confirm the validity of our hypothesis 
proposing that the evolution of longevity regulation mechanisms within an ecosystem can 
be driven by the xenohormetic, hormetic and cytostatic selective forces created by a 
lasting exposure of an organism to an anti-aging natural compound released by other 
organisms composing this ecosystem. 
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6 Conclusions and suggestions for future work 
We designed a chemical genetic screen for small molecules that increase the 
chronological life span (CLS) of yeast under CR by targeting lipid metabolism and 
modulating housekeeping longevity pathways that regulate longevity irrespective of the 
number of available calories. By screening the total of approximately 19,000 
representative compounds from seven commercial libraries, we identified 24 small 
molecules that greatly extend the CLS of a short-lived mutant pex5' deficient in 
peroxisomal fatty acid oxidation, which we used for our high-throughput screen. These 
anti-aging small molecules belong to 5 chemical groups. Group I consisted of 6 bile 
acids, including lithocholic acid (LCA), deoxycholic acid, chenodeoxycholic acid, cholic 
acid, dehydrocholic acid and hyodeoxycholic acid. The results of our pharmacophore 
modeling of the anti-aging potential of various species of bile acids imply that the 
maintenance of the minimal polarity of both the hydrophilic (concave) and hydrophobic 
(convex) sides of the steroid nucleus - by avoiding the presence of polar substituents at 
the positions 6, 7 and 12 - is mandatory for the extreme life-extending efficacy of LCA 
under CR conditions. Such stringent structural requirements are consistent with a target 
specificity of LCA action as an anti-aging small molecule. We found that the life-
extending efficacy of LCA under CR exceeds that under non-CR conditions, being 
inversely proportional to the concentration of glucose in growth medium and thus in 
correlation with the extent of calorie supply limitation.  
 
Yeast do not synthesize this or any other bile acids produced by mammals [168, 169]. We 
noticed that various organisms (i.e., bacteria, fungi, plants and animals) within an 
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ecosystem can synthesize and release into the environment certain longevity-extending 
small molecules. We therefore hypothesized that these interspecies chemical signals can 
create xenohormetic, hormetic and cytostatic selective forces driving the ecosystemic 
evolution of longevity regulation mechanisms. In our hypothesis, following their release 
into the environment by one species of the organisms composing an ecosystem, such 
small molecules can activate anti-aging processes and/or inhibit pro-aging processes in 
other species within the ecosystem. The organisms that possess the most effective (as 
compared to their counterparts of the same species) mechanisms for sensing the chemical 
signals produced and released by other species and for responding to such signals by 
undergoing certain hormetic and/or cytostatic life-extending changes to their metabolism 
and physiology are expected to live longer than their counterparts within the ecosystem. 
We therefore proposed that the ability of a species of the organisms composing an 
ecosystem to undergo life-extending metabolic or physiological changes in response to 
hormetic or cytostatic chemical compounds released to the ecosystem by other species: 1) 
increases its chances of survival; 2) creates selective forces aimed at maintaining such 
ability; and 3) enables the evolution of longevity regulation mechanisms. 
 
To verify our hypothesis empirically, we carried out the LCA-driven multistep selection 
of long-lived yeast species under laboratory conditions. We found that a lasting exposure 
of wild-type yeast to LCA results in selection of yeast species that live longer in the 
absence of this bile acid than their ancestor. Our data enabled to rank different 
concentrations of LCA with respect to the efficiency with which they cause the 
appearance of long-lived yeast species. We revealed that, if used at the most efficient 
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concentration of 5 μM, this bile acid induced life-extending mutations with the frequency 
of about 4 × 108/generation. At the concentration of 50 μM, LCA caused the appearance 
of long-lived species with the frequency of 1 × 108/generation, whereas a lasting 
exposure of yeast to 250 μM LCA did not result in selection of such species. Because the 
lowest used concentration of LCA resulted in the highest frequency of long-lived species 
appearance, we believe that it is unlikely that the life-extending mutations they carry are 
due to mutagenic action of this bile acid. 
 
We found that the evolved under laboratory conditions long-lived yeast species 3, 5 and 
12 were able to maintain their greatly extended CLS following numerous successive 
passages in medium without LCA under CR conditions. Our data imply that each of these 
long-lived yeast species also exhibited extended CLS when cultured in the absence of 
LCA under non-CR conditions (although to a lesser extent than that under CR 
conditions). Thus, consistent with its sought-after effect on longevity regulation 
pathways, our LCA-driven multistep selection process under laboratory conditions 
yielded long-lived yeast species whose greatly delayed chronological aging was caused 
by the selection of a mutant allele or alleles that activate so-called housekeeping 
longevity assurance pathways. These housekeeping longevity assurance pathways 
modulate longevity irrespective of the number of available calories and do not overlap 




To test the validity of other aspects of our hypothesis on the ecosystemic evolution of 
longevity regulation mechanisms, we assessed how a mutant allele or alleles selected 
during the LCA-driven multistep selection process of long-lived yeast species 3, 5 and 12 
influence a compendium of the housekeeping longevity-related processes that, as we 
recently revealed [167], are modulated by LCA in chronologically aging yeast. We found 
that in the absence of LCA this allele or alleles alter the age-dependent dynamics of 
mitochondrial respiration under both CR and non-CR conditions. This finding further 
confirms our conclusion that, consistent with its sought-after effect on longevity 
regulation pathways, our LCA-driven multistep selection process under laboratory 
conditions yielded long-lived yeast species whose greatly delayed chronological aging 
was caused by the selection of a mutant allele or alleles that activate so-called 
housekeeping longevity assurance pathways. As we previously demonstrated, these 
housekeeping longevity assurance pathways modulate longevity irrespective of the 
number of available calories and do not overlap with the adaptable longevity pathways 
that are under the stringent control of calorie availability [167]. 
 
We also revealed that under CR conditions in the absence of LCA a mutant allele or 
alleles selected during the LCA-driven multistep selection process of long-lived yeast 
species: 1) enhance the resistance of yeast to chronic oxidative, thermal and osmotic 
stresses; 2) suppress mitochondria-controlled apoptotic cell death triggered by 
exogenously added hydrogen peroxide; and 3) attenuate lipid-induced necrotic cell death 
induced by exogenously added palmitoleic acid. All these processes are known to be 
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governed by the housekeeping longevity assurance pathways that modulate longevity 
irrespective of the number of available calories [167].  
 
We also revealed that the addition of LCA to long-lived yeast species 3, 5 and 12 
cultured under CR conditions 1) further extends their CLS, although to a lesser degree 
than that of WT; 2) causes further changes in the age-dependent dynamics of 
mitochondrial respiration, although not as dramatic as those seen in WT; 3) further 
enhances the resistance of yeast to chronic oxidative, thermal and osmotic stresses, 
although to a lesser extent than those observed in WT; 4) further suppresses 
mitochondria-controlled apoptotic cell death triggered by exogenously added hydrogen 
peroxide, although to a lesser degree than those seen in WT; and 5) further attenuates 
lipid-induced necrotic cell death induced by exogenously added palmitoleic acid, 
although to a lesser extent than those observed in WT. We therefore concluded that, 
although a mutant allele or alleles selected during the LCA-driven multistep selection 
process of long-lived yeast species 3, 5 and 12 greatly impact a compendium of the LCA-
sensing housekeeping longevity assurance processes, this allele or alleles do not activate 
such processes sufficiently enough to attain the maximal CLS achievable under life-
extending CR conditions in the presence of LCA.  
 
Altogether, the findings presented in this Master’s thesis further confirm the validity of 
our hypothesis in which the evolution of longevity regulation mechanisms within an 
ecosystem can be driven by the xenohormetic, hormetic and cytostatic selective forces 
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created by a lasting exposure of an organism to an anti-aging natural compound released 
by other organisms composing this ecosystem. 
  
Future studies may involve an empirical test of the antagonistic pleiotropy and life 
history optimization theories of aging [232, 233]. One may consider analyzing the trade-
offs between early-life fitness and longevity by measuring the relative fitness of the 
selected long-lived yeast species in a direct competition assay with the parental WT strain 
[234]. The assay could be carried out under CR conditions, which mimic the natural 
stressful environment of cyclical starvation, as well as under non-CR conditions in a 
more favourable environment [234, 235]. It would be very interesting to see if any of the 
three laboratory-evolved long-lived yeast species exhibits reduced fitness in the direct 
competition assay with WT cells.  
 
We expect that these experiments using the three laboratory-evolved long-lived yeast 
species will reveal the trade-offs between early-life fitness and longevity. The subsequent 
studies of the molecular and cellular mechanisms underlying the anticipated trade-offs 
between early-life fitness and longevity would first assess if any of the laboratory-
evolved long-lived yeast species has reduced fecundity, which could be monitored as 
their mating and sporulation efficacies. Furthermore, one could then elucidate if the 
decreased relative fitness of each of these species under field-like CR conditions of 
cyclical starvation is due to a reduction in maximal growth rate early in life.  
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Finally, it would be important in the near future to test if the greatly extended longevity 
of the laboratory-evolved long-lived yeast species is a monogenic trait. That could 
provide important information complementary to the ongoing effort of sequencing the 
entire genomes of these yeast species in an attempt to establish, for the first time, the 
molecular landscape of the evolution of longevity under laboratory conditions.    
 
This future work may result in a unified hypothesis of the natural selection forces and 
underlying molecular mechanisms that drive the evolution of yeast longevity and 
maintain a finite yeast lifespan within ecosystems. 
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